Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
  • Curriculum.
  • Publikationen.
  • Projekte.
  • Präsentationen.
  • Betreute Dipl u. Diss.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Zigeuner Richard |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2025

Originalarbeit (Zeitschrift)

** Contieri, R; Martini, A; Beijert, IJ; Mertens, LS; Hentschel, AE; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Subiela, Henríquez, JD; Hernández, V; de, la, Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Maxim, Bruins, H; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Seisen, T; Claps, F; Masson-Lecomte, A; Liedberg, F; Cohen, D; Lunelli, L; Cussenot, O; Sheikh, SE; Volanis, D; Côté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; de, Kaa, CAH; van, der, Heijden, AG; Kiemeney, LALM; Soukup, V; Molinaro, L; Hurle, R; Paciotti, M; Moschini, M; Pradere, B; Perdonà, S; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Ribal, MJ; van, der, Kwast, TH; Babjuk, M; Sylvester, RJ; van, Rhijn, BWG Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2025; Doi: 10.1016/j.euo.2025.04.010
PubMed FullText FullText_MUG

 

2024

Originalarbeit (Zeitschrift)

** Beijert, IJ; Hentschel, AE; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Subiela, Henríquez, JD; Hernández, V; de, la, Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Bruins, HM; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Cotte, J; Contieri, R; Mertens, LS; Claps, F; Masson-Lecomte, A; Liedberg, F; Cohen, D; Lunelli, L; Cussenot, O; El, Sheikh, S; Volanis, D; Côté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; Hulsbergen-van, de, Kaa, CA; van, der, Heijden, AG; Kiemeney, LALM; Soukup, V; Molinaro, L; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Ribal, MJ; van, der, Kwast, TH; Babjuk, M; Sylvester, RJ; van, Rhijn, BWG Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
Int Urol Nephrol. 2024; 56(4):1323-1333 Doi: 10.1007/s11255-023-03867-9
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Contieri, R; Beijert, ; Martini, A; Camperat, EM; Hernandez, ; Bruins, HM; Dominguez-Escrig, JL; Liedberg, F; Masson-Lecomte, A; Cohen, D; Mostafid, H; Shariat, SF; Roupret, M; Pradere, B; Zigeuner, R; Soria, F; Soukup, ; Redorta, JP; Capoun, O; Burger, M; Gontero, P; Sylvester, R; Mertens, L; Van Rhijn, BWG Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.
EUR UROL. 2024; 85: S1164-S1165.-39th Annual EAU Congress; APR 5-8,2024; Paris, FRANCE. [Poster]
Web of Science

 

** Gontero, P; Soria, F; Babjuk, M; Burger, M; Comperat, E; Mostafid, H; Redorta, JP; Roupret, M; Van Rhijn, BW; Zigeuner, R; Shariat, SF; Cohen, D; Masson-Lecomte, A; Xylinas, E; Mariappan, P; Rai, BP; Capoun, O; Soukup, V; Thalmann, G; Pradere, B; Seisen, T; Dominguez-Escrig, JL; Liedberg, F; Sylvester, RJ Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multicentre retrospective study.
EUR UROL. 2024; 85: S1870-S1871.-39th Annual EAU Congress; APR 5-9, 2024; Paris, FRANCE. [Poster]
Web of Science

 

** Scheipner, L; Zurl, H; Altziebler, JV; Pichler, GP; Schöpfer-Schwab, S; Jasarevic, S; Gaisl, M; Pohl, KC; Pemberger, K; Andlar, S; Hutterer, GC; Bele, U; Leitsmann, C; Leitsmann, M; Augustin, H; Zigeuner, R; Ahyai, S; Mischinger, J Charlson-Deyo Comorbidity Index as a novel predictor for recurrence in nonmuscle invasive bladder cancer
EUR UROL. 2024; 85: S2123-S2124. [Oral Communication]
Web of Science

 

2023

Originalarbeit (Zeitschrift)

** Beijert, IJ; Hentschel, AE; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Subiela, Henríquez, JD; Hernández, V; de, la, Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Bruins, HM; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Cotte, J; Mertens, LS; Claps, F; Masson-Lecomte, A; Liedberg, F; Cohen, D; Lunelli, L; Cussenot, O; El, Sheikh, S; Volanis, D; Côté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; Hulsbergen-van, de, Kaa, CA; van, der, Heijden, AG; Kiemeney, LALM; Soukup, V; Molinaro, L; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Ribal, MJ; van, der, Kwast, TH; Babjuk, M; Sylvester, RJ; van, Rhijn, BWG Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Eur Urol Oncol. 2023; 6(2):214-221 Doi: 10.1016/j.euo.2023.01.004
Web of Science PubMed FullText FullText_MUG

 

** Egger, V; Hutterer, GC; Mischinger, J; Seles, M; Pichler, R; Mannweiler, S; Huber, K; Balihodzic, A; Spiegelberg, J; Bauernhofer, T; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
World J Urol. 2023; 41(5):1359-1364 Doi: 10.1007/s00345-023-04379-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipner, L; Zurl, H; Altziebler, JV; Pichler, GP; Schöpfer-Schwab, S; Jasarevic, S; Gaisl, M; Pohl, KC; Pemberger, K; Andlar, S; Hutterer, GC; Bele, U; Leitsmann, C; Leitsmann, M; Augustin, H; Zigeuner, R; Ahyai, S; Mischinger, J Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2023; 15(24): Doi: 10.3390/cancers15245770 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Korrektur

** Sylvester, RJ; Rodríguez, O; Hernández, V; Turturica, D; Bauerová, L; Max, Bruins, H; Bründl, J; van, der, Kwast, TH; Brisuda, A; Rubio-Briones, J; Seles, M; Hentschel, AE; Kusuma, VRM; Huebner, N; Cotte, J; Mertens, LS; Volanis, D; Cussenot, O; Subiela, Henríquez, JD; de, la, Peña, E; Pisano, F; Pešl, M; van, der, Heijden, AG; Herdegen, S; Zlotta, AR; Hacek, J; Calatrava, A; Mannweiler, S; Bosschieter, J; Ashabere, D; Haitel, A; Côté, JF; El, Sheikh, S; Lunelli, L; Algaba, F; Alemany, I; Soria, F; Runneboom, W; Breyer, J; Nieuwenhuijzen, JA; Llorente, C; Molinaro, L; Hulsbergen-van, de, Kaa, CA; Evert, M; Kiemeney, LALM; N'Dow, J; Plass, K; Čapoun, O; Soukup, V; Dominguez-Escrig, JL; Cohen, D; Palou, J; Gontero, P; Burger, M; Zigeuner, R; Mostafid, AH; Shariat, SF; Rouprêt, M; Compérat, EM; Babjuk, M; van, Rhijn, BWG Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].
Eur Urol. 2023; 83(5):e140-e141 Doi: 10.1016/j.eururo.2023.02.007
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gontero, P; Soria, F; Babjuk, M; Burger, M; Comperat, EM; Mostafid, H; Palou, RJ; Roupret, M; Van, RBW; Zigeuner, R; Shariat, SF; Cohen, D; Masson-Lecomte, A; Hernandez, V; Xylinas, E; Capoun, O; Thalmann, G; Pradere, B; Linares, E; Soukup, V; Seisen, T; Dominguez-Escrig, J; Liedberg, F; Sylvester, RJ Do current definitions of BCG failure/ BCG unresponsive NMIBCs correlate with disease progression? Results of an individual patient data validation international multi-center retrospective study
EUR UROL. 2023; 83: [Poster]
Web of Science

 

2022

Originalarbeit (Zeitschrift)

** Beijert, IJ; Hentschel, AE; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Subiela, Henríquez, JD; Hernández, V; de, la, Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Maxim, Bruins, H; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Cotte, J; Mertens, LS; Masson-Lecomte, A; Liedberg, F; Cohen, D; Lunelli, L; Cussenot, O; El, Sheikh, S; Volanis, D; Côté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; Hulsbergen-van, de, Kaa, CA; van, der, Heijden, AG; A, L, M, Kiemeney, L; Soukup, V; Molinaro, L; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Ribal, MJ; van, der, Kwast, TH; Babjuk, M; Sylvester, RJ; van, Rhijn, BWG T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Eur Urol Focus. 2022; 8(6):1627-1634 Doi: 10.1016/j.euf.2022.04.014
Web of Science PubMed FullText FullText_MUG

 

** Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065 Doi: 10.1177/17588359221134065 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353 Doi: 10.1016/j.clgc.2022.03.010
Web of Science PubMed FullText FullText_MUG

 

** Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389 Doi: 10.3389/fsurg.2022.1013389 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2021

Originalarbeit (Zeitschrift)

** Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16 Doi: 10.1016/j.urolonc.2021.06.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Mischinger, J; Zigeuner, R Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con.
Eur Urol Open Sci. 2021; 32: 35-37. Doi: 10.1016/j.euros.2021.08.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sylvester, RJ; Rodríguez, O; Hernández, V; Turturica, D; Bauerová, L; Bruins, HM; Bründl, J; van der Kwast, TH; Brisuda, A; Rubio-Briones, J; Seles, M; Hentschel, AE; Kusuma, VRM; Huebner, N; Cotte, J; Mertens, LS; Volanis, D; Cussenot, O; Subiela Henríquez, JD; de la Peña, E; Pisano, F; Pešl, M; van der Heijden, AG; Herdegen, S; Zlotta, AR; Hacek, J; Calatrava, A; Mannweiler, S; Bosschieter, J; Ashabere, D; Haitel, A; Côté, JF; El Sheikh, S; Lunelli, L; Algaba, F; Alemany, I; Soria, F; Runneboom, W; Breyer, J; Nieuwenhuijzen, JA; Llorente, C; Molinaro, L; Hulsbergen-van de Kaa, CA; Evert, M; Kiemeney, LALM; N'Dow, J; Plass, K; Čapoun, O; Soukup, V; Dominguez-Escrig, JL; Cohen, D; Palou, J; Gontero, P; Burger, M; Zigeuner, R; Mostafid, AH; Shariat, SF; Rouprêt, M; Compérat, EM; Babjuk, M; van Rhijn, BWG European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
Eur Urol. 2021; 79(4):480-488 Doi: 10.1016/j.eururo.2020.12.033
Web of Science PubMed FullText FullText_MUG

 

** van Rhijn, BWG; Hentschel, AE; Bründl, J; Compérat, EM; Hernández, V; Čapoun, O; Bruins, HM; Cohen, D; Rouprêt, M; Shariat, SF; Mostafid, AH; Zigeuner, R; Dominguez-Escrig, JL; Burger, M; Soukup, V; Gontero, P; Palou, J; van der Kwast, TH; Babjuk, M; Sylvester, RJ; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973 WHO 2004 2016 Classification Systems for Grade Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
Eur Urol Oncol. 2021; 4(2):182-191 Doi: 10.1016/j.euo.2020.12.002
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Rouprêt, M; Babjuk, M; Burger, M; Capoun, O; Cohen, D; Compérat, EM; Cowan, NC; Dominguez-Escrig, JL; Gontero, P; Hugh Mostafid, A; Palou, J; Peyronnet, B; Seisen, T; Soukup, V; Sylvester, RJ; Rhijn, BWGV; Zigeuner, R; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
Eur Urol. 2021; 79(1):62-79 Doi: 10.1016/j.eururo.2020.05.042 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Originalarbeit (Zeitschrift)

** Hentschel, AE; van Rhijn, BWG; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Henríquez, JDS; Hernández, V; de la Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Bruins, HM; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Scavarda-Lamberti, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Cotte, J; Mertens, LS; Cohen, D; Lunelli, L; Cussenot, O; Sheikh, SE; Volanis, D; Coté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; Hulsbergen-van de Kaa, CA; van der Heijden, AG; Kiemeney, LALM; Soukup, V; Molinaro, L; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Babjuk, M; van der Kwast, TH; Sylvester, RJ Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Urol Oncol. 2020; 38(5):440-448 Doi: 10.1016/j.urolonc.2019.10.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Cancers (Basel). 2020; 12(5): 1200 Doi: 10.3390/cancers12051200 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Witjes, JA; Babjuk, M; Bellmunt, J; Bruins, HM; De Reijke, TM; De Santis, M; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, MJ; Shariat, SF; Der Kwast, TV; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, PC; Bochner, BH; Bolla, M; Boormans, JL; Bossi, A; Briganti, A; Brummelhuis, I; Burger, M; Castellano, D; Cathomas, R; Chiti, A; Choudhury, A; Compérat, E; Crabb, S; Culine, S; De Bari, B; De Blok, W; J L De Visschere, P; Decaestecker, K; Dimitropoulos, K; Dominguez-Escrig, JL; Fanti, S; Fonteyne, V; Frydenberg, M; Futterer, JJ; Gakis, G; Geavlete, B; Gontero, P; Grubmüller, B; Hafeez, S; Hansel, DE; Hartmann, A; Hayne, D; Henry, AM; Hernandez, V; Herr, H; Herrmann, K; Hoskin, P; Huguet, J; Jereczek-Fossa, BA; Jones, R; Kamat, AM; Khoo, V; Kiltie, AE; Krege, S; Ladoire, S; Lara, PC; Leliveld, A; Linares-Espinós, E; Løgager, V; Lorch, A; Loriot, Y; Meijer, R; Mir, MC; Moschini, M; Mostafid, H; Müller, AC; Müller, CR; N'Dow, J; Necchi, A; Neuzillet, Y; Oddens, JR; Oldenburg, J; Osanto, S; J G Oyen, W; Pacheco-Figueiredo, L; Pappot, H; Patel, MI; Pieters, BR; Plass, K; Remzi, M; Retz, M; Richenberg, J; Rink, M; Roghmann, F; Rosenberg, JE; Rouprêt, M; Rouvière, O; Salembier, C; Salminen, A; Sargos, P; Sengupta, S; Sherif, A; Smeenk, RJ; Smits, A; Stenzl, A; Thalmann, GN; Tombal, B; Turkbey, B; Lauridsen, SV; Valdagni, R; Van Der Heijden, AG; Van Poppel, H; Vartolomei, MD; Veskimäe, E; Vilaseca, A; Rivera, FAV; Wiegel, T; Wiklund, P; Williams, A; Zigeuner, R; Horwich, A EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort^†: Under the Auspices of the EAU-ESMO Guidelines Committees.
Eur Urol. 2020; 77(2):223-250 Doi: 10.1016/j.eururo.2019.09.035 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Soukup, V; Čapoun, O; Cohen, D; Hernández, V; Burger, M; Compérat, E; Gontero, P; Lam, T; Mostafid, AH; Palou, J; van Rhijn, BWG; Rouprêt, M; Shariat, SF; Sylvester, R; Yuan, Y; Zigeuner, R; Babjuk, M Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel.
Eur Urol Focus. 2020; 6(3):479-489 Doi: 10.1016/j.euf.2018.11.005
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Mostafid, H; Babjuk, M; Bochner, B; Lerner, SP; Witjes, F; Palou, J; Roupret, M; Shariat, S; Gontero, P; van Rhijn, B; Zigeuner, R; Sylvester, R; Comperat, E; Burger, M; Malavaud, B; Soloway, M; Williams, S; Black, P; Daneshmand, S; Steinberg, G; Brausi, M; Catto, J; Kamat, AM Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer.
Eur Urol. 2020; 77(6):669-670 Doi: 10.1016/j.eururo.2020.03.005
Web of Science PubMed FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Dominguez-Escrig, JL; Peyronnet, B; Seisen, T; Bruins, HM; Yuan, CY; Babjuk, M; Böhle, A; Burger, M; Compérat, EM; Gontero, P; Lam, T; MacLennan, S; Mostafid, H; Palou, J; van Rhijn, BWG; Sylvester, RJ; Zigeuner, R; Shariat, SF; Rouprêt, M Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
Eur Urol Focus. 2019; 5(2):224-241 Doi: 10.1016/j.euf.2017.09.015
Web of Science PubMed FullText FullText_MUG

 

** González, J; Gaynor, JJ; Martínez-Salamanca, JI; Capitanio, U; Tilki, D; Carballido, JA; Chantada, V; Daneshmand, S; Evans, CP; Gasch, C; Gontero, P; Haferkamp, A; Huang, WC; Espinós, EL; Master, VA; McKiernan, JM; Montorsi, F; Pahernik, S; Palou, J; Pruthi, RS; Rodriguez-Faba, O; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Vera-Donoso, C; Zigeuner, R; Hohenfellner, M; Libertino, JA; Ciancio, G Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma.
Eur J Surg Oncol. 2019; 45(10):1983-1992 Doi: 10.1016/j.ejso.2019.05.009 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hager, B; Herzog, SA; Hager, B; Sandner-Kiesling, A; Zigeuner, R; Pummer, K Comparison of early postoperative pain after partial tumour nephrectomy by flank, transabdominal or laparoscopic access.
BRIT J PAIN. 2019; 13(3): 177-184. Doi: 10.1177/2049463718808542 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Horwich, A; Babjuk, M; Bellmunt, J; Bruins, HM; De Reijke, TM; De Santis, M; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, MJ; Shariat, SF; Van der Kwast, T; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, PC; Bochner, BH; Bolla, M; Boormans, JL; Bossi, A; Briganti, A; Brummelhuis, I; Burger, M; Castellano, D; Cathomas, R; Chiti, A; Choudhury, A; Comperat, E; Crabb, S; Culine, S; De Bari, B; De Blok, W; De Visschere, PJL; Decaestecker, K; Dimitropoulos, K; Dominguez-Escrig, JL; Fanti, S; Fonteyne, V; Frydenberg, M; Futterer, JJ; Gakis, G; Geavlete, B; Gontero, P; Grubmuller, B; Hafeez, S; Hansel, DE; Hartmann, A; Hayne, D; Henry, AM; Hernandez, V; Herr, H; Herrmann, K; Hoskin, P; Huguet, J; Jereczek-Fossa, BA; Jones, R; Kamat, AM; Khoo, V; Kiltie, AE; Krege, S; Ladoire, S; Lara, PC; Leliveld, A; Linares-Espinos, E; Logager, V; Lorch, A; Loriot, Y; Meijer, R; Mir, MC; Moschini, M; Mostafid, H; Muller, AC; Muller, CR; N'Dow, J; Necchi, A; Neuzillet, Y; Oddens, JR; Oldenburg, J; Osanto, S; Oyen, WJG; Pacheco-Figueiredo, L; Pappot, H; Patel, MI; Pieters, BR; Plass, K; Remzi, M; Retz, M; Richenberg, J; Rink, M; Roghmann, F; Rosenberg, JE; Roupret, M; Rouviere, O; Salembier, C; Salminen, A; Sargos, P; Sengupta, S; Sherif, A; Smeenk, RJ; Smits, A; Stenzl, A; Thalmann, GN; Tombal, B; Turkbey, B; Lauridsen, SV; Valdagni, R; Van der Heijden, AG; Van Poppel, H; Vartolomei, MD; Veskimae, E; Vilaseca, A; Rivera, FAV; Wiegel, T; Wiklund, P; Williams, A; Zigeuner, R; Witjes, JA EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
ANN ONCOL. 2019; 30(11): 1697-1727. Doi: 10.1093/annonc/mdz296 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Posch, F; Buser, L; Zigeuner, R; Morshäuser, L; Otto, W; Wild, PJ; Burger, M; May, M; Pichler, M; Brookman-May, SD BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urol Oncol. 2019; 37(7): 510-518. Doi: 10.1016/j.urolonc.2019.04.004
Web of Science PubMed FullText FullText_MUG

 

** Mischinger, J; Fröhlich, E; Mannweiler, S; Meindl, C; Absenger-Novak, M; Hutterer, GC; Seles, M; Augustin, H; Chromecki, TF; Jesche-Chromecki, J; Pummer, K; Zigeuner, R Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Cent European J Urol. 2019; 72(1): 23-31. Doi: 10.5173/ceju.2018.1858 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Peyronnet, B; Seisen, T; Dominguez-Escrig, JL; Bruins, HM; Yuan, CY; Lam, T; Maclennan, S; N'dow, J; Babjuk, M; Comperat, E; Zigeuner, R; Sylvester, RJ; Burger, M; Mostafid, H; van Rhijn, BWG; Gontero, P; Palou, J; Shariat, SF; Roupret, M Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Eur Urol Focus. 2019; 5(2):205-223 Doi: 10.1016/j.euf.2017.10.003
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Babjuk, M; Burger, M; Compérat, EM; Gontero, P; Mostafid, AH; Palou, J; van Rhijn, BWG; Rouprêt, M; Shariat, SF; Sylvester, R; Zigeuner, R; Capoun, O; Cohen, D; Escrig, JLD; Hernández, V; Peyronnet, B; Seisen, T; Soukup, V European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
Eur Urol. 2019; 76(5):639-657 Doi: 10.1016/j.eururo.2019.08.016
Web of Science PubMed FullText FullText_MUG

 

** Compérat, EM; Burger, M; Gontero, P; Mostafid, AH; Palou, J; Rouprêt, M; van Rhijn, BWG; Shariat, SF; Sylvester, RJ; Zigeuner, R; Babjuk, M Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".
Eur Urol Focus. 2019; 5(3):457-466 Doi: 10.1016/j.euf.2018.01.003
Web of Science PubMed FullText FullText_MUG

 

2018

Originalarbeit (Zeitschrift)

** Marra, G; Gontero, P; Brattoli, M; Filippini, C; Capitanio, U; Montorsi, F; Daneshmand, S; Huang, WC; Linares Espinós, E; Martínez-Salamanca, JI; McKiernan, JM; Zigeuner, R; Libertino, JA Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort.
UROL ONCOL-SEMIN ORI. 2018; 36(7): 339.e1-339339. Doi: 10.1016/j.urolonc.2018.04.007
Web of Science PubMed FullText FullText_MUG

 

** Tilki, D; Chandrasekar, T; Capitanio, U; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Linares Espinós, E; Lorentz, A; Martinez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Rodriguez-Faba, O; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Vera-Donoso, C; Zigeuner, R; Libertino, JA; Evans, CP Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Urol Oncol. 2018; 36(2):79.e11-79.e79 Doi: 10.1016/j.urolonc.2017.10.008 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Rouprêt, M; Babjuk, M; Compérat, E; Zigeuner, R; Sylvester, RJ; Burger, M; Cowan, NC; Gontero, P; Van Rhijn, BWG; Mostafid, AH; Palou, J; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
Eur Urol. 2018; 73(1):111-122 Doi: 10.1016/j.eururo.2017.07.036
Web of Science PubMed FullText FullText_MUG

 

2017

Originalarbeit (Zeitschrift)

** Babjuk, M; Böhle, A; Burger, M; Capoun, O; Cohen, D; Compérat, EM; Hernández, V; Kaasinen, E; Palou, J; Rouprêt, M; van Rhijn, BW; Shariat, SF; Soukup, V; Sylvester, RJ; Zigeuner, R EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Eur Urol. 2017; 71(3):447-461 Doi: 10.1016/j.eururo.2016.05.041
Web of Science PubMed FullText FullText_MUG

 

** Borgmann, H; Musquera, M; Haferkamp, A; Vilaseca, A; Klatte, T; Shariat, SF; Scavuzzo, A; Jimenez Rios, MA; Wolff, I; Capitanio, U; Dell'Oglio, P; Krabbe, LM; Herrmann, E; Ecke, T; Vergho, D; Huck, N; Wagener, N; Pahernik, S; Zastrow, S; Wirth, M; Surcel, C; Mirvald, C; Prochazkova, K; Hutterer, G; Zigeuner, R; Cindolo, L; Hora, M; Stief, CG; May, M; Brookman-May, SD Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
World J Urol. 2017; 35(12):1891-1897 Doi: 10.1007/s00345-017-2078-5
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Krieger, D; Ehrlich, GC; Pohlmann, K; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma.
Urol Int. 2017; 98(3):320-327 Doi: 10.1159/000452109
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90 Doi: 10.1038/bjc.2016.393 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Krabbe, LM; Eminaga, O; Shariat, SF; Hutchinson, RC; Lotan, Y; Sagalowsky, AI; Raman, JD; Wood, CG; Weizer, AZ; Roscigno, M; Montorsi, F; Bolenz, C; Novara, G; Kikuchi, E; Fajkovic, H; Rapoport, LM; Glybochko, PV; Zigeuner, R; Remzi, M; Bensalah, K; Kassouf, W; Margulis, V Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma.
J Urol. 2017; 197(3 Pt 1):580-589 Doi: 10.1016/j.juro.2016.09.078
Web of Science PubMed FullText FullText_MUG

 

** May, M; Surcel, C; Capitanio, U; Dell'Oglio, P; Klatte, T; Shariat, S; Ecke, T; Wolff, I; Vergho, D; Wagener, N; Huck, N; Pahernik, S; Zastrow, S; Wirth, M; Borgmann, H; Haferkamp, A; Musquera, M; Krabbe, LM; Herrmann, E; Scavuzzo, A; Mirvald, C; Hutterer, G; Zigeuner, R; Stief, CG; Waidelich, R; Cindolo, L; Kalusova, K; Brookman-May, SD; Collaborative Research On Renal Neoplasms Association (CORONA) and European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
Scand J Urol. 2017; 51(4):269-276 Doi: 10.1080/21681805.2017.1300187
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
J Urol. 2017; 198(6):1247-1252 Doi: 10.1016/j.juro.2017.07.036
Web of Science PubMed FullText FullText_MUG

 

** Soukup, V; Čapoun, O; Cohen, D; Hernández, V; Babjuk, M; Burger, M; Compérat, E; Gontero, P; Lam, T; MacLennan, S; Mostafid, AH; Palou, J; van Rhijn, BWG; Rouprêt, M; Shariat, SF; Sylvester, R; Yuan, Y; Zigeuner, R Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
Eur Urol. 2017; 72(5):801-813 Doi: 10.1016/j.eururo.2017.04.015
Web of Science PubMed FullText FullText_MUG

 

** Wagener, N; Edelmann, D; Benner, A; Zigeuner, R; Borgmann, H; Wolff, I; Krabbe, LM; Musquera, M; Dell'Oglio, P; Capitanio, U; Klatte, T; Cindolo, L; May, M; Brookman-May, SD; European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
PLOS ONE. 2017; 12(9): e0184173-e0184173. Doi: 10.1371/journal.pone.0184173 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zigeuner, R Bladder cancer in 2016: News in diagnosis, treatment, and risk group assessment.
Nat Rev Urol. 2017; 14(2):74-76 Doi: 10.1038/nrurol.2016.264
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Artinger, K; Knizacek, C; Hessl, A; Meinitzer, A; Zigeuner, R; Muller, H; Mauric, A; Filipic, K; Schemmer, P; Rosenkranz, AR; Zitta, S DYNAMIC OF MEASURED GLOMERULAR FILTRATION RATE (MGFR) IN LIVING KIDNEY DONORS BEFORE AND AFTER KIDNEY DONATION
TRANSPL INT. 2017; 30: 307-307. [Poster]
Web of Science

 

** Marra, G; Gontero, P; Brattoli, M; Capitanio, U; Daneshmand, S; Huang, WC; Espinos, EL; Martinez-Salamanca, JI; Mckiernan, JM; Montorsi, F; Scherr, DS; Zigeuner, R; Libertino, JA IMPERATIVE PARTIAL NEPHRECTOMY VERSUS RADICAL NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS THROMBUS
ANTICANCER RES. 2017; 37(4):2118-2119. [Poster]
Web of Science

 

Kommentar

** Babjuk, M; Burger, M; Compérat, E; Palou, J; Rouprêt, M; van Rhijn, B; Shariat, S; Sylvester, R; Zigeuner, R; Gontero, P; Mostafid, H Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61.
EUR UROL. 2017; 71(6): e173-e174-e173-e174. Doi: 10.1016/j.eururo.2016.11.029
Web of Science PubMed FullText FullText_MUG

 

2016

Originalarbeit (Zeitschrift)

** Becker, A; Hickmann, D; Hansen, J; Meyer, C; Rink, M; Schmid, M; Eichelberg, C; Strini, K; Chromecki, T; Jesche, J; Regier, M; Randazzo, M; Tilki, D; Ahyai, S; Dahlem, R; Fisch, M; Zigeuner, R; Chun, FK Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
Eur J Surg Oncol. 2016; 42(3):419-25 Doi: 10.1016/j.ejso.2015.09.023
Web of Science PubMed FullText FullText_MUG

 

** Mager, R; Daneshmand, S; Evans, CP; Palou, J; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Libertino, JA; Haferkamp, A; International Renal Cell Carcinoma-Venous Thrombus Consortium; Haferkamp, A; Capitanio, U; Carballido, JA; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; González, J; Hohenfellner, M; Huang, WC; Koppie, TM; Libertino, JA; Espinós, EL; Lorentz, A; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; O'Malley, P; Pahernik, S; Palou, J; Moreno, JL; Pruthi, RS; Faba, OR; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vázquez-Martul, D; Donoso, CV; Vergho, D; Wallen, EM; Zigeuner, R Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
J Surg Oncol. 2016; 114(6):764-768 Doi: 10.1002/jso.24395 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Meyer, C; Hansen, J; Becker, A; Schmid, M; Pradel, L; Strini, K; Chromecki, T; Jesche-Chromecki, J; Fisch, M; Zigeuner, R; Chun, FK The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and Germany.
Urol Int. 2016; 96(3):330-336 Doi: 10.1159/000442215
Web of Science PubMed FullText FullText_MUG

 

** Seisen, T; Peyronnet, B; Dominguez-Escrig, JL; Bruins, HM; Yuan, CY; Babjuk, M; Böhle, A; Burger, M; Compérat, EM; Cowan, NC; Kaasinen, E; Palou, J; van Rhijn, BW; Sylvester, RJ; Zigeuner, R; Shariat, SF; Rouprêt, M Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Eur Urol. 2016; 70(6):1052-1068 Doi: 10.1016/j.eururo.2016.07.014
Web of Science PubMed FullText FullText_MUG

 

** Simone, G; De Nunzio, C; Ferriero, M; Cindolo, L; Brookman-May, S; Papalia, R; Sperduti, I; Collura, D; Leonardo, C; Anceschi, U; Tuderti, G; Misuraca, L; Dalpiaz, O; Hatzl, S; Lodde, M; Trenti, E; Pastore, AL; Palleschi, G; Lotrecchiano, G; Salzano, L; Carbone, A; De Cobelli, O; Tubaro, A; Schips, L; Zigeuner, R; Tostain, J; May, M; Guaglianone, S; Muto, G; Gallucci, M Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset.
Eur J Surg Oncol. 2016; 42(11):1729-1735 Doi: 10.1016/j.ejso.2016.03.022
Web of Science PubMed FullText FullText_MUG

 

** Wolff, I; May, M; Hoschke, B; Zigeuner, R; Cindolo, L; Hutterer, G; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, MD; Salzano, L; Lotrecchiano, G; Shariat, SF; Hohenfellner, M; Waidelich, R; Stief, C; Miller, K; Pahernik, S; Brookman-May, S; Members of the CORONA Project and the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
Eur J Surg Oncol. 2016; 42(5):744-750 Doi: 10.1016/j.ejso.2016.01.009
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Artinger, K; Knizacek, C; Hessl, A; Meinitzer, A; Zigeuner, R; Muller, H; Kniepeiss, D; Mauric, A; Filipic, K; Rosenkranz, AR; Zitta, S DYNAMICS OF THE MEASURED GLOMERULA FILTRATION RATE FOR KIDNEY LIVING DONOR BEFORE AND AFTER THE DONATION
TRANSPL INT. 2016; 29: 11-11. [Poster]
Web of Science

 

2015

Originalarbeit (Zeitschrift)

** Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35 Doi: 10.1016/j.juro.2015.01.083
Web of Science PubMed FullText FullText_MUG

 

** Brookman-May, SD; May, M; Wolff, I; Zigeuner, R; Hutterer, GC; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Feciche, B; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, Mdel C; Salzano, L; Lotrecchiano, G; Zastrow, S; Wirth, M; Sountoulides, P; Shariat, S; Waidelich, R; Stief, C; Gunia, S; CORONA Project; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
Eur Urol. 2015; 67(5):943-951 Doi: 10.1016/j.eururo.2014.11.055 [Poster]
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551 Doi: 10.1136/jclinpath-2014-202683
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Krieger, D; Mrsic, E; Pohlmann, K; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Anticancer Res. 2015; 35(6):3463-3469
Web of Science PubMed

 

** Hutterer, GC; Sobolev, N; Ehrlich, GC; Gutschi, T; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R; Pichler, M; Dalpiaz, O Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
J Clin Pathol. 2015; 68(5):351-355 Doi: 10.1136/jclinpath-2014-202658
Web of Science PubMed FullText FullText_MUG

 

** Nguyen, HG; Tilki, D; Dall'Era, MA; Durbin-Johnson, B; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Espinós, EL; Mandel, P; Martinez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Rodriguez-Faba, O; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.
J Urol. 2015; 194(2):304-308 Doi: 10.1016/j.juro.2015.02.2948 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rouprêt, M; Babjuk, M; Compérat, E; Zigeuner, R; Sylvester, RJ; Burger, M; Cowan, NC; Böhle, A; Van Rhijn, BW; Kaasinen, E; Palou, J; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Eur Urol. 2015; 68(5):868-879 Doi: 10.1016/j.eururo.2015.06.044
Web of Science PubMed FullText FullText_MUG

 

** Tilki, D; Hu, B; Nguyen, HG; Dall'Era, MA; Bertini, R; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Linares, E; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Thieu, W; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
J Urol. 2015; 193(2):436-442 Doi: 10.1016/j.juro.2014.07.087
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Brookman-May, SD; May, M; Zigeuner, R; Cindolo, L; Shariat, SF; Wirth, M; Gunia, S Prognostic significance of perirenal fat invasion and tumor size in pT1 to pT3a renal cell carcinoma: Results of a comprehensive multicenter study of the CORONA project-Can we improve prognostic discrimination of patients with stage pT3a tumors?
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL. Doi: 10.1200/jco.2015.33.7_suppl.416 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years.
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL. Doi: 10.1200/jco.2015.33.7_suppl.513 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents): A European single-center experience over 26 years
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.e15617 [Poster]
Web of Science FullText FullText_MUG

 

2014

Originalarbeit (Zeitschrift)

** Aziz, A; May, M; Zigeuner, R; Pichler, M; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Hoschke, B; Gilfrich, C; Feciche, B; Fenske, F; Sountoulides, P; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Del Carmen Santiago Martin, M; Wieland, WF; Salzano, L; Lotrecchiano, G; Waidelich, R; Stief, C; Brookman-May, S; Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database.
J Urol. 2014; 191(2):310-315 Doi: 10.1016/j.juro.2013.08.021
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Ehrlich, G; Quehenberger, F; Pummer, K; Zigeuner, R Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter.
Urol Oncol. 2014; 32(1):34.e1-34.e8 Doi: 10.1016/j.urolonc.2013.01.001
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Ehrlich, GC; Mannweiler, S; Hernández, JM; Gerger, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
BJU Int. 2014; 114(3):334-339 Doi: 10.1111/bju.12441 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mannweiler, S; Martín Hernández, JM; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Br J Cancer. 2014; 110(10):2531-2536 Doi: 10.1038/bjc.2014.180 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hofer, D; Münzker, J; Schwetz, V; Ulbing, M; Hutz, K; Stiegler, P; Zigeuner, R; Pieber, TR; Müller, H; Obermayer-Pietsch, B Testicular synthesis and vitamin D action.
J Clin Endocrinol Metab. 2014; 99(10):3766-3773 Doi: 10.1210/jc.2014-1690 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Jesche, J; Eberhard, K; Pummer, K; Zigeuner, R; Pichler, M Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Urol Oncol. 2014; 32(7):1041-1048 Doi: 10.1016/j.urolonc.2014.04.001
Web of Science PubMed FullText FullText_MUG

 

** Kluth, LA; Xylinas, E; Kent, M; Hagiwara, M; Kikuchi, E; Ikeda, M; Matsumoto, K; Dalpiaz, O; Zigeuner, R; Aziz, A; Fritsche, HM; Deliere, A; Raman, JD; Bensalah, K; Al-Matar, B; Gakis, G; Novara, G; Klatte, T; Remzi, M; Comploj, E; Pycha, A; Rouprêt, M; Tagawa, ST; Chun, FK; Scherr, DS; Vickers, AJ; Shariat, SF Predictors of survival in patients with disease recurrence after radical nephroureterectomy.
BJU Int. 2014; 113(6):911-917 Doi: 10.1111/bju.12369 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** M Al-Ali, B; Gutschi, T; Pummer, K; Zigeuner, R; Brookman-May, S; Wieland, WF; Fritsche, HM; Aziz, A Body mass index has no impact on sperm quality but on reproductive hormones levels.
Andrologia. 2014; 46(2):106-111 Doi: 10.1111/and.12051
Web of Science PubMed FullText FullText_MUG

 

** May, M; Cindolo, L; Zigeuner, R; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Wolff, I; Feciche, B; Fenske, F; Pichler, M; Schips, L; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, Mdel C; Salzano, L; Lotrecchiano, G; Waidelich, R; Stief, C; Sountoulides, P; Brookman-May, S; Members of CORONA project; Young Academic Urologists Renal Cancer Group Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.
Urol Oncol. 2014; 32(8):1252-1258 Doi: 10.1016/j.urolonc.2014.04.013
Web of Science PubMed FullText FullText_MUG

 

** May, M; Zigeuner, R; Aziz, A; Cindolo, L; Gilfrich, C; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Hoschke, B; Dalpiaz, O; Stoltze, A; Fenske, F; Fritsche, HM; Chromecki, T; Lebentrau, S; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Del Carmen Santiago Martin, M; Salzano, L; Lotrecchiano, G; Joniau, S; Waidelich, R; Stief, CG; Brookman-May, S; Mitglieder des "CORONA projects"; Projektgruppe "Young Academic Urologists Renal Cancer Group" der European Association of Urology (EAU) [Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database].
Urologe A. 2014; 53(2):228-235 Doi: 10.1007/s00120-013-3237-y
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Dalpiaz, O; Ehrlich, GC; Stojakovic, T; Martín Hernández, JM; Mannweiler, S; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
J Urol. 2014; 191(4):920-925 Doi: 10.1016/j.juro.2013.10.073
Web of Science PubMed FullText FullText_MUG

 

** Seisen, T; Colin, P; Hupertan, V; Yates, DR; Xylinas, E; Nison, L; Cussenot, O; Neuzillet, Y; Bensalah, K; Novara, G; Montorsi, F; Zigeuner, R; Remzi, M; Shariat, SF; Rouprêt, M Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis.
BJU Int. 2014; 114(5):733-740 Doi: 10.1111/bju.12631 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Tilki, D; Nguyen, HG; Dall'Era, MA; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Eur Urol. 2014; 66(3):577-583 Doi: 10.1016/j.eururo.2013.06.048
Web of Science PubMed FullText FullText_MUG

 

** Xylinas, E; Rink, M; Cha, EK; Clozel, T; Lee, RK; Fajkovic, H; Comploj, E; Novara, G; Margulis, V; Raman, JD; Lotan, Y; Kassouf, W; Fritsche, HM; Weizer, A; Martinez-Salamanca, JI; Matsumoto, K; Zigeuner, R; Pycha, A; Scherr, DS; Seitz, C; Walton, T; Trinh, QD; Karakiewicz, PI; Matin, S; Montorsi, F; Zerbib, M; Shariat, SF; Upper Tract Urothelial Carcinoma Collaboration Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2014; 65(1):210-217 Doi: 10.1016/j.eururo.2012.04.052
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Martínez-Salamanca, JI; Linares, E; González, J; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Nguyen, HG; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Faba, OR; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Curr Urol Rep. 2014; 15(5):404-404 Doi: 10.1007/s11934-014-0404-7
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bagrodia, A; Krabbe, LM; Gayed, BA; Kapur, P; Darwish, OM; Bernstein, I; Xie, XJ; Wood, CG; Zigeuner, R; Weizer, AZ; Raman, JD; Remzi, M; Langner, C; Roscigno, M; Bolenz, C; Bensalah, K; Sagalowsky, AI; Shariat, SF; Lotan, Y; Margulis, V Multi-institutional evaluation of the prognostic significance of altered mammalian target of rapamycin (mTOR) pathway biomarkers in upper-tract urothelial carcinoma (UTUC)
J CLIN ONCOL. 2014; 32(4):-Genitourinary Cancers Symposium; JAN 30-FEB 01, 2014; San Francisco, USA. Doi: 10.1200/jco.2014.32.4_suppl.323 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4): Doi: 10.1200/jco.2014.32.4_suppl.534 [Poster]
Web of Science FullText FullText_MUG

 

Kommentar

** Zigeuner, R Word of wisdom. Re: clinical outcomes for patients with metastatic renal cell carcinoma treated with alternative sunitinib schedules.
Eur Urol. 2014; 66(4):785-785 Doi: 10.1016/j.eururo.2014.07.048
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Brookman-May, S; May, M; Ficarra, V; Kainz, MC; Kampel-Kettner, K; Kohlschreiber, S; Wenzl, V; Schneider, M; Burger, M; Wieland, WF; Otto, W; Tilki, D; Gilfrich, C; Hohenfellner, M; Pahernik, S; Chromecki, TF; Stief, C; Zigeuner, R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
World J Urol. 2013; 31(5):1309-1316 Doi: 10.1007/s00345-012-0931-0
Web of Science PubMed FullText FullText_MUG

 

** Brookman-May, S; May, M; Shariat, SF; Xylinas, E; Stief, C; Zigeuner, R; Chromecki, T; Burger, M; Wieland, WF; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Feciche, B; Truss, M; Gilfrich, C; Pahernik, S; Hohenfellner, M; Zastrow, S; Wirth, MP; Novara, G; Carini, M; Minervini, A; Simeone, C; Antonelli, A; Mirone, V; Longo, N; Simonato, A; Carmignani, G; Ficarra, V; Members of the CORONA project and the SATURN project Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Eur Urol. 2013; 64(3):472-477 Doi: 10.1016/j.eururo.2012.06.030
Web of Science PubMed FullText FullText_MUG

 

** Brookman-May, S; May, M; Shariat, SF; Zigeuner, R; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Feciche, B; Coman, I; Truss, M; Pahernik, S; Wirth, MP; Zastrow, S; Dalpiaz, O; Fenske, F; Waidelich, R; Stief, C; Gunia, S; Members of the CORONA Project Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.
Clin Genitourin Cancer. 2013; 11(4):465-470 Doi: 10.1016/j.clgc.2013.04.026
Web of Science PubMed FullText FullText_MUG

 

** Brookman-May, SD; May, M; Shariat, SF; Novara, G; Zigeuner, R; Cindolo, L; De Cobelli, O; De Nunzio, C; Pahernik, S; Wirth, MP; Longo, N; Simonato, A; Serni, S; Siracusano, S; Volpe, A; Morgia, G; Bertini, R; Dalpiaz, O; Stief, C; Ficarra, V; Members of the CORONA-Project; Members of the SATURN-Project; Young Academic Urologists Renal Cancer Group Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
BJU Int. 2013; 112(7):909-916 Doi: 10.1111/bju.12246 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** El-Heliebi, A; Kroneis, T; Zöhrer, E; Haybaeck, J; Fischereder, K; Kampel-Kettner, K; Zigeuner, R; Pock, H; Riedl, R; Stauber, R; Geigl, JB; Huppertz, B; Sedlmayr, P; Lackner, C Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
J Transl Med. 2013; 11(10):214-214 Doi: 10.1186/1479-5876-11-214 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fajkovic, H; Cha, EK; Xylinas, E; Rink, M; Pycha, A; Seitz, C; Bolenz, C; Dunning, A; Novara, G; Trinh, QD; Karakiewicz, PI; Margulis, V; Raman, JD; Walton, TJ; Baba, S; Carballido, J; Otto, W; Montorsi, F; Lotan, Y; Kassouf, W; Fritsche, HM; Bensalah, K; Zigeuner, R; Scherr, DS; Sonpavde, G; Roupret, M; Shariat, SF Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
World J Urol. 2013; 31(1):5-11 Doi: 10.1007/s00345-012-0939-5
Web of Science PubMed FullText FullText_MUG

 

** Fajkovic, H; Klatte, T; Nagele, U; Dunzinger, M; Zigeuner, R; Hübner, W; Remzi, M Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience.
World J Urol. 2013; 31(1):37-44 Doi: 10.1007/s00345-012-0948-4
Web of Science PubMed FullText FullText_MUG

 

** Hafner-Giessauf, H; Mauric, A; Müller, H; Eller, P; Zigeuner, R; Iberer, F; Rosenkranz, AR; Eller, K Long-term outcome of en bloc pediatric kidney transplantation in adult recipients - up to 22 years of center experience.
Ann Transplant. 2013; 18(19-20):101-107 Doi: 10.12659/AOT.883845
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Pichler, M; Chromecki, TF; Strini, KA; Klatte, T; Pummer, K; Remzi, M; Mannweiler, S; Zigeuner, R Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.
Histopathology. 2013; 63(3):309-315 Doi: 10.1111/his.12163
Web of Science PubMed FullText FullText_MUG

 

** May, M; Aziz, A; Zigeuner, R; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Hoschke, B; Gilfrich, C; Feciche, B; Stoltze, A; Fenske, F; Fritsche, HM; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Martin, Mdel C; Salzano, L; Lotrecchiano, G; Joniau, S; Waidelich, R; Stief, C; Brookman-May, S; Members of the CORONA project the Young Academic Urologists Renal Cancer Group Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.
World J Urol. 2013; 31(5):1073-1080 Doi: 10.1007/s00345-013-1071-x
Web of Science PubMed FullText FullText_MUG

 

** May, M; Ficarra, V; Shariat, SF; Zigeuner, R; Chromecki, T; Cindolo, L; Burger, M; Gunia, S; Feciche, B; Wenzl, V; Aziz, A; Chun, F; Becker, A; Pahernik, S; Simeone, C; Longo, N; Zucchi, A; Antonelli, A; Mirone, V; Stief, C; Novara, G; Brookman-May, S; CORONA and SATURN projects; Young Academic Urologists Renal Cancer Group Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
J Urol. 2013; 190(2):458-463 Doi: 10.1016/j.juro.2013.02.035
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Hoefler, G; Pummer, K; Zigeuner, R Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Histopathology. 2013; 62(2):237-246 Doi: 10.1111/his.12001
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Pummer, K; Zigeuner, R Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
BJU Int. 2013; 111(4 Pt B):E191-E195 Doi: 10.1111/j.1464-410X.2012.11584.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Pummer, K; Mannweiler, S; Zigeuner, R Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.
Histopathology. 2013; 62(2):219-228 Doi: 10.1111/j.1365-2559.2012.04328.x
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Eberhard, K; Gerger, A; Mannweiler, S; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Br J Cancer. 2013; 108(4):901-907 Doi: 10.1038/bjc.2013.28 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
Br J Cancer. 2013; 109(5):1123-1129 Doi: 10.1038/bjc.2013.443 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rouprêt, M; Babjuk, M; Compérat, E; Zigeuner, R; Sylvester, R; Burger, M; Cowan, N; Böhle, A; Van Rhijn, BW; Kaasinen, E; Palou, J; Shariat, SF; European Association of Urology European guidelines on upper tract urothelial carcinomas: 2013 update.
Eur Urol. 2013; 63(6):1059-1071 Doi: 10.1016/j.eururo.2013.03.032
Web of Science PubMed FullText FullText_MUG

 

** Roupret, M; Hupertan, V; Seisen, T; Colin, P; Xylinas, E; Yates, DR; Fajkovic, H; Lotan, Y; Raman, JD; Zigeuner, R; Remzi, M; Bolenz, C; Novara, G; Kassouf, W; Ouzzane, A; Rozet, F; Cussenot, O; Martinez-Salamanca, JI; Fritsche, HM; Walton, TJ; Wood, CG; Bensalah, K; Karakiewicz, PI; Montorsi, F; Margulis, V; Shariat, SF; Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve Analysis.
J Urol. 2013; 189(5):1662-1669 Doi: 10.1016/j.juro.2012.10.057
Web of Science PubMed FullText FullText_MUG

 

** Schneider, NI; Zigeuner, R; Langner, C Small Cell Carcinoma of the Urinary Bladder: A Rare Tumor with Propensity for Hepatic Involvement.
Am J Med Sci. 2013; 345(2):155-157 Doi: 10.1097/MAJ.0b013e3182648759 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Youssef, RF; Lotan, Y; Sagalowsky, AI; Shariat, SF; Wood, CG; Raman, JD; Langner, C; Zigeuner, R; Roscigno, M; Montorsi, F; Bolenz, C; Kassouf, W; Margulis, V Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
Int Braz J Urol. 2013; 39(5):614-621 Doi: 10.1590/S1677-5538.IBJU.2013.05.02 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Youssef, RF; Shariat, SF; Lotan, Y; Cost, N; Wood, CG; Sagalowsky, AI; Zigeuner, R; Langner, C; Chromecki, TF; Montorsi, F; Bolenz, C; Margulis, V Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
Urol Oncol. 2013; 31(5):676-681 Doi: 10.1016/j.urolonc.2011.05.006
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Babjuk, M; Burger, M; Zigeuner, R; Shariat, SF; van Rhijn, BW; Compérat, E; Sylvester, RJ; Kaasinen, E; Böhle, A; Palou Redorta, J; Rouprêt, M; European Association of Urology EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Eur Urol. 2013; 64(4):639-653 Doi: 10.1016/j.eururo.2013.06.003
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hofer, D; Münzker, J; Hutz, K; Zigeuner, R; Stiegler, Ph; Müller, H; Pieber, TR; Obermayer-Pietsch, B. Etablierung eines Zellkulturmodells für Fertilitätsstudien bei Männern.
17-18/13 Wiener klinische Wochenschrift. 2013; 125(17-18):556-556.-ÖGIM Jahrestagung; SEPT 26-28, 2013; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R A LARGE SCALE VALIDATION STUDY PROPOSES HIGH PRE-OPERATIVE PLASMA FIBRINOGEN LEVELS AS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR REGARDING CANCER-SPECIFIC, METASTASIS-FREE, AS WELL AS OVERALL SURVIVAL IN A EUROPEAN COHORT OF RENAL CELL CARCINOMA PATIENTS
J UROLOGY. 2013; 189(4): E300-E301. Doi: 10.1016/j.juro.2013.02.294 [Poster]
Web of Science FullText FullText_MUG

 

2012

Originalarbeit (Zeitschrift)

** Adibi, M; Youssef, R; Shariat, SF; Lotan, Y; Wood, CG; Sagalowsky, AI; Zigeuner, R; Montorsi, F; Bolenz, C; Margulis, V Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades.
Int J Urol. 2012; 19(12):1060-1066 Doi: 10.1111/j.1442-2042.2012.03110.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bornemann-Cimenti, H; Lederer, AJ; Wejbora, M; Michaeli, K; Kern-Pirsch, C; Archan, S; Rumpold-Seitlinger, G; Zigeuner, R; Sandner-Kiesling, A Preoperative pregabalin administration significantly reduces postoperative opioid consumption and mechanical hyperalgesia after transperitoneal nephrectomy.
Br J Anaesth. 2012; 108(5): 845-849. Doi: 10.1093/bja/aes004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Cha, EK; Shariat, SF; Kormaksson, M; Novara, G; Chromecki, TF; Scherr, DS; Lotan, Y; Raman, JD; Kassouf, W; Zigeuner, R; Remzi, M; Bensalah, K; Weizer, A; Kikuchi, E; Bolenz, C; Roscigno, M; Koppie, TM; Ng, CK; Fritsche, HM; Matsumoto, K; Walton, TJ; Ehdaie, B; Tritschler, S; Fajkovic, H; Martinez-Salamanca, JI; Pycha, A; Langner, C; Ficarra, V; Patard, JJ; Montorsi, F; Wood, CG; Karakiewicz, PI; Margulis, V Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2012; 61(4):818-825 Doi: 10.1016/j.eururo.2012.01.021
Web of Science PubMed FullText FullText_MUG

 

** Chromecki, TF; Cha, EK; Fajkovic, H; Margulis, V; Novara, G; Scherr, DS; Lotan, Y; Raman, JD; Kassouf, W; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Walton, TJ; Pycha, A; Ficarra, V; Karakiewicz, PI; Zigeuner, R; Pummer, K; Shariat, SF The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Eur Urol. 2012; 61(2): 245-253. Doi: 10.1016/j.eururo.2011.09.017
Web of Science PubMed FullText FullText_MUG

 

** Lughezzani, G; Burger, M; Margulis, V; Matin, SF; Novara, G; Roupret, M; Shariat, SF; Wood, CG; Zigeuner, R Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
Eur Urol. 2012; 62(1):100-114 Doi: 10.1016/j.eururo.2012.02.030
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma.
J Urol. 2012; 187(3):834-839 Doi: 10.1016/j.juro.2011.10.155
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Eberhard, K; Hoefler, G; Pummer, K; Zigeuner, R Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
J Clin Pathol. 2012; 65(8):721-724 Doi: 10.1136/jclinpath-2012-200797
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival.
Int Urol Nephrol. 2012; 44(4):997-1004 Doi: 10.1007/s11255-012-0165-5
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.
Am J Clin Pathol. 2012; 137(2): 283-289. Doi: 10.1309/AJCPLBK9L9KDYQZP [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rink, M; Sjoberg, D; Comploj, E; Margulis, V; Xylinas, E; Lee, RK; Hansen, J; Cha, EK; Raman, JD; Remzi, M; Bensalah, K; Novara, G; Matin, SF; Chun, FK; Kikuchi, E; Kassouf, W; Martinez-Salamanca, JI; Lotan, Y; Seitz, C; Pycha, A; Zigeuner, R; Karakiewicz, PI; Scherr, DS; Vickers, AJ; Shariat, SF Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.
Ann Surg Oncol. 2012; 19(13):4337-4344 Doi: 10.1245/s10434-012-2499-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Roupret, M; Zigeuner, R; Palou, J; Boehle, A; Kaasinen, E; Sylvester, R; Babjuk, M; Oosterlinck, W; European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract.
Actas Urol Esp. 2012; 36(1): 2-14. Doi: 10.1016/j.acuro.2011.09.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Shariat, SF; Zigeuner, R; Rink, M; Margulis, V; Hansen, J; Kikuchi, E; Kassouf, W; Raman, JD; Remzi, M; Koppie, TM; Bensalah, K; Guo, CC; Mikami, S; Sircar, K; Ng, CK; Haitel, A; Kabbani, W; Chun, FK; Wood, CG; Scherr, DS; Karakiewicz, PI; Langner, C Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification.
Eur Urol. 2012; 62(2):224-231 Doi: 10.1016/j.eururo.2012.01.019
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Becker, A; Hansen, J; Eichelberg, C; Heuer, R; Meyer, CP; Adam, M; Kampel-Kettner, K; Kainz, MC; Chromecki, T; Jesche, J; Zigeuner, R; Chun, KHF A simplified 2 or 3 graded Fuhrman grading system for clear cell renal cell carcinoma could predict cancer-specific-survival as accurate as the traditional 4 graded system in patients from 2 tertiary care centers in Europe
EUR UROL SUPPL. 2012; 11(1): E1021-U136. [Poster]
Web of Science

 

** Brookman-May, S; May, M; Burger, M; Denzinger, S; Otto, W; Hoschke, B; Wieland, WF; Rossler, W; Wenzl, V; Kohlschreiber, S; Chromecki, T; Pahernik, S; Hohenfellner, M; Zigeuner, R Thrombocytosis is associated with a significant increase in cancer specific death rate after nephrectomy for patients with renal cell carcinoma
EUR UROL SUPPL. 2012; 11(1): E1019-U132. [Poster]
Web of Science

 

** Brookman-May, SD; May, M; Zigeuner, R; Chromecki, T; Shariat, SF; Burger, M; Wieland, WF; Cindolo, L; Wirth, MP; Pahernik, S; Zastrow, S Collecting system invasion and Fuhrman grading but not tumour size facilitate prognostic stratification of patients with pT2 renal cell carcinoma - can the current 7th edition of TNM classification be improved?
EUR UROL SUPPL. 2012; 11(1): E1015-U124. [Poster]
Web of Science

 

** Dalpiaz, O; Ehrlich, G; Galle, G; Pummer, K; Zigeuner, R Distal ureterectomy for urothelial carcinoma of the distal ureter: A single institutional experience
EUR UROL SUPPL. 2012; 11(1): E772-U639. [Poster]
Web of Science

 

2011

Originalarbeit (Zeitschrift)

** Brookman-May, S; May, M; Zigeuner, R; Shariat, SF; Scherr, DS; Chromecki, T; Moch, H; Wild, PJ; Mohamad-Al-Ali, B; Cindolo, L; Wieland, WF; Schips, L; De Cobelli, O; Rocco, B; Santoro, L; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Hohenfellner, M; Gilfrich, C; Wirth, MP; Burger, M; Pahernik, S; CORONA Project (Collaborative Research on Renal Neoplasms Association) Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
J Urol. 2011; 186(6): 2175-2181. Doi: 10.1016/j.juro.2011.07.105
Web of Science PubMed FullText FullText_MUG

 

** Chromecki, TF; Ehdaie, B; Novara, G; Pummer, K; Zigeuner, R; Seitz, C; Pycha, A; Lee, RK; Cha, EK; Karakiewicz, PI; Ng, C; Raman, JD; Chun, FK; Fritsche, HM; Matsumoto, K; Kassouf, W; Walton, TJ; Bastian, PJ; Martnez-Salamanca, JI; Scherr, DS; Shariat, SF Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
WORLD J UROL. 2011; 29(4): 473-480. Doi: 10.1007/s00345-011-0677-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gurbuz, C; Youssef, RF; Shariat, SF; Lotan, Y; Wood, CG; Sagalowsky, AI; Zigeuner, R; Kikuchi, E; Weizer, A; Raman, JD; Remzi, M; Roscigno, M; Montorsi, F; Bolenz, C; Kassouf, W; Margulis, V The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
J Endourol. 2011; 25(5):775-779 Doi: 10.1089/end.2010.0396 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Marszalek, M; Chromecki, T; Al-Ali, BM; Meixl, H; Madersbacher, S; Jeschke, K; Pummer, K; Zigeuner, R Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approach.
Urology. 2011; 77(1): 109-113. Doi: 10.1016/j.urology.2010.02.057
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Matsumoto, K; Novara, G; Gupta, A; Margulis, V; Walton, TJ; Roscigno, M; Ng, C; Kikuchi, E; Zigeuner, R; Kassouf, W; Fritsche, HM; Ficarra, V; Martignoni, G; Tritschler, S; Rodriguez, JC; Seitz, C; Weizer, A; Remzi, M; Raman, JD; Bolenz, C; Bensalah, K; Koppie, TM; Karakiewicz, PI; Wood, CG; Montorsi, F; Iwamura, M; Shariat, SF Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU Int. 2011; 108(8b): E304-E309. Doi: 10.1111/j.1464-410X.2011.10188.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology.
J Urol. 2011; 186(5):1773-1777 Doi: 10.1016/j.juro.2011.07.034
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Rouprêt, M; Zigeuner, R; Palou, J; Boehle, A; Kaasinen, E; Sylvester, R; Babjuk, M; Oosterlinck, W European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.
Eur Urol. 2011; 59(4): 584-594. Doi: 10.1016/j.eururo.2010.12.042
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Youssef, RF; Shariat, SF; Lotan, Y; Wood, CG; Sagalowsky, AI; Zigeuner, R; Kikuchi, E; Weizer, A; Raman, JD; Remzi, M; Kabbani, W; Langner, C; Guo, CC; Roscigno, M; Montorsi, F; Bolenz, C; Kassouf, W; Margulis, V Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
BJU Int. 2011; 108(8): 1286-1291. Doi: 10.1111/j.1464-410X.2011.10075.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Youssef, RF; Shariat, SF; Lotan, Y; Wood, CG; Sagalowsky, AI; Zigeuner, R; Langner, C; Montorsi, F; Bolenz, C; Margulis, V Prognostic Effect of Urinary Bladder Carcinoma In Situ on Clinical Outcome of Subsequent Upper Tract Urothelial Carcinoma.
Urology. 2011; 77(4): 861-866. Doi: 10.1016/j.urology.2010.09.032
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Roscigno, M; Brausi, M; Heidenreich, A; Lotan, Y; Margulis, V; Shariat, SF; Van Poppel, H; Zigeuner, R Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
Eur Urol. 2011; 60(4): 776-783. Doi: 10.1016/j.eururo.2011.07.009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Sun, M; Shariat, SF; Cheng, C; Ficarra, V; Murai, M; Oudard, S; Pantuck, AJ; Zigeuner, R; Karakiewicz, PI Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
Eur Urol. 2011; 60(4): 644-661. Doi: 10.1016/j.eururo.2011.06.041
Web of Science PubMed FullText FullText_MUG

 

2010

Originalarbeit (Zeitschrift)

** Klatte, T; Remzi, M; Zigeuner, RE; Mannweiler, S; Said, JW; Kabbinavar, FF; Haitel, A; Waldert, M; de Martino, M; Marberger, M; Belldegrun, AS; Pantuck, AJ Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
J UROL. 2010; 184(1): 53-58. Doi: 10.1016/j.juro.2010.03.026
Web of Science PubMed FullText FullText_MUG

 

** Margulis, V; Youssef, RF; Karakiewicz, PI; Lotan, Y; Wood, CG; Zigeuner, R; Kikuchi, E; Weizer, A; Raman, JD; Remzi, M; Roscigno, M; Montorsi, F; Bolenz, C; Kassouf, W; Shariat, SF; Upper Tract Urothelial Carcinoma Collaborative Group Preoperative Multivariable Prognostic Model for Prediction of Nonorgan Confined Urothelial Carcinoma of the Upper Urinary Tract.
J Urol. 2010; 184(2): 453-458. Doi: 10.1016/j.juro.2010.03.142
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Mohamad Al-Ali, B; Trummer, H; Shamloul, R; Zigeuner, R; Pummer, K Is treatment of hemorrhagic radiation cystitis with hyperbaric oxygen effective?
Urol Int. 2010; 84(4): 467-470. Doi: 10.1159/000296289
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Raman, JD; Ng, CK; Scherr, DS; Margulis, V; Lotan, Y; Bensalah, K; Patard, JJ; Kikuchi, E; Montorsi, F; Zigeuner, R; Weizer, A; Bolenz, C; Koppie, TM; Isbarn, H; Jeldres, C; Kabbani, W; Remzi, M; Waldert, M; Wood, CG; Roscigno, M; Oya, M; Langner, C; Wolf, JS; Strobel, P; Fernandez, M; Karakiewcz, P; Shariat, SF Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
EUR UROL. 2010; 57(6): 1072-1079. Doi: 10.1016/j.eururo.2009.07.002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Shariat, SF; Godoy, G; Lotan, Y; Droller, M; Karakiewicz, PI; Raman, JD; Isbarn, H; Weizer, A; Remzi, M; Roscigno, M; Kikuchi, E; Bolenz, C; Bensalah, K; Koppie, TM; Kassouf, W; Wheat, JC; Zigeuner, R; Langner, C; Wood, CG; Margulis, V Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy.
BJU Int. 2010; 105(12): 1672-1677. Doi: 10.1111/j.1464-410X.2009.09072.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wheat, JC; Weizer, AZ; Wolf, JS; Lotan, Y; Remzi, M; Margulis, V; Wood, CG; Montorsi, F; Roscigno, M; Kikuchi, E; Zigeuner, R; Langner, C; Bolenz, C; Koppie, TM; Raman, JD; Fernndez, M; Karakiewizc, P; Capitanio, U; Bensalah, K; Patard, JJ; Shariat, SF Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
Urol Oncol. 2010; 30(3):252-258 Doi: 10.1016/j.urolonc.2010.01.001
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Eur Urol. 2010; 57(1):102-9 Doi: 10.1016/j.eururo.2008.11.033
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Shariat, SF; Margulis, V; Karakiewicz, PI; Roscigno, M; Weizer, A; Kikuchi, E; Remzi, M; Raman, JD; Bolenz, C; Bensalah, K; Capitanio, U; Koppie, TM; Kassouf, W; Sircar, K; Patard, JJ; Fernández, MI; Wood, CG; Montorsi, F; Ströbel, P; Wheat, JC; Haitel, A; Oya, M; Guo, CC; Ng, C; Chade, DC; Sagalowsky, A; Langner, C Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
Eur Urol. 2010; 57(4):575-581 Doi: 10.1016/j.eururo.2009.11.035
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Editorial

** Zigeuner, R Editorial Comment on: Factors Predicting Health-Related Quality of Life Recovery in Patients Undergoing Surgical Treatment for Renal Tumors: Prospective Evaluation Using the RAND SF-36 Health Survey.
Eur Urol. 2010; 57(1): 121-122. Doi: 10.1016/j.eururo.2009.04.025
Web of Science PubMed FullText FullText_MUG

 

** Zigeuner, R; Langner, C Reply from Authors re: Guido Dalbagni. Prognostication of Upper Tract Urothelial Carcinoma: What Do We Really Need? Eur Urol 2010;57:582-3.
Eur Urol. 2010; 57(4): 583-585. Doi: 10.1016/j.eururo.2010.01.009
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Al-Ali, BEM; Hebel, P; Pummer, K; Zigeuner, R; Mache, C 23 CASES OF PAEDIATRIC RENAL TRANSPLANTATION ONE CENTER OWN EXPERIENCE, WITH A LONG TIME FOLLOW-UP
EUR UROL SUPPL. 2010; 9(6):647-647.-25th Anniversary EAU Congress; APR 16-20, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

** Gutschi, T; Pachernegg, O; Heidler, S; Zigeuner, R; Pummer, K; Lackner, K DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH RENAL CELL CARCINOMA COMPARED WITH A CONTROL GROUP
EUR UROL SUPPL. 2010; 9(6):649-649.-25th Anniversary EAU Congress; APR 16-20, 2010; Barcelona, SPAIN. Doi: 10.1016/S1569-9056(10)61648-X [Poster]
Web of Science FullText FullText_MUG

 

2009

Originalarbeit (Zeitschrift)

** Bolenz, C; Shariat, SF; Fernández, MI; Margulis, V; Lotan, Y; Karakiewicz, P; Remzi, M; Kikuchi, E; Zigeuner, R; Weizer, A; Montorsi, F; Bensalah, K; Wood, CG; Roscigno, M; Langner, C; Koppie, TM; Raman, JD; Mikami, S; Michel, MS; Ströbel, P Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
BJU Int. 2009; 103(3): 302-306. Doi: 10.1111/j.1464-410X.2008.07988.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Capitanio, U; Jeldres, C; Patard, JJ; Perrotte, P; Zini, L; de La Taille, A; Ficarra, V; Cindolo, L; Bensalah, K; Artibani, W; Tostain, J; Valeri, A; Zigeuner, R; Méjean, A; Descotes, JL; Lechevallier, E; Mulders, PF; Lang, H; Jacqmin, D; Karakiewicz, PI Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
BJU Int. 2009; 103(1): 33-37. Doi: 10.1111/j.1464-410X.2008.08014.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Capitanio, U; Shariat, SF; Isbarn, H; Weizer, A; Remzi, M; Roscigno, M; Kikuchi, E; Raman, JD; Bolenz, C; Bensalah, K; Koppie, TM; Kassouf, W; Fernandez, MI; Strobel, P; Wheat, J; Zigeuner, R; Langner, C; Waldert, M; Oya, M; Guo, CC; Ng, C; Montorsi, F; Wood, CG; Margulis, V; Larakiewicz, PI Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases
EUR UROL. 2009; 56(1): 1-9. Doi: 10.1016/j.eururo.2009.03.072
Web of Science FullText FullText_MUG Google Scholar

 

** Fernández, MI; Shariat, SF; Margulis, V; Bolenz, C; Montorsi, F; Suardi, N; Remzi, M; Wood, CG; Roscigno, M; Kikuchi, E; Oya, M; Zigeuner, R; Langner, C; Weizer, A; Lotan, Y; Koppie, TM; Raman, JD; Karakiewizc, P; Bensalah, K; Schultz, M; Bernier, P Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
Urology. 2009; 73(1): 142-146. Doi: 10.1016/j.urology.2008.07.042
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gidaro, S; Cindolo, L; Lipsky, K; Zigeuner, R; Schips, L Efficacy and safety of the haemostasis achieved by Vivostat system during laparoscopic partial nephrectomy.
Arch Ital Urol Androl. 2009; 81(4): 223-227.
PubMed Google Scholar

 

** Hellenthal, NJ; Shariat, SF; Margulis, V; Karakiewicz, PI; Roscigno, M; Bolenz, C; Remzi, M; Weizer, A; Zigeuner, R; Bensalah, K; Ng, CK; Raman, JD; Kikuchi, E; Montorsi, F; Oya, M; Wood, CG; Fernandez, M; Evans, CP; Koppie, TM Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration.
J UROL. 2009; 182(3): 900-906. Doi: 10.1016/j.juro.2009.05.011
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jeldres, C; Sun, M; Liberman, D; Lughezzani, G; de la Taille, A; Tostain, J; Valeri, A; Cindolo, L; Ficarra, V; Artibani, W; Zigeuner, R; Mejean, A; Descotes, JL; Lechevallier, E; Mulders, PF; Perrotte, P; Patard, JJ; Karakiewicz, PI Can Renal Mass Biopsy Assessment of Tumor Grade be Safely Substituted for by a Predictive Model?
J UROL. 2009; 182(6): 2585-2589. Doi: 10.1016/j.juro.2009.08.053
Web of Science FullText FullText_MUG Google Scholar

 

** Karakiewicz, PI; Suardi, N; Capitanio, U; Isbarn, H; Jeldres, C; Perrotte, P; Sun, M; Ficarra, V; Zigeuner, R; Tostain, J; Mejean, A; Cindolo, L; Pantuck, AJ; Belldegrun, AS; Zini, L; de la Taille, A; Chautard, D; Descotes, JL; Shariat, SF; Valeri, A; Mulders, PFA; Lang, H; Lechevallier, E; Patard, JJ Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma
J UROL. 2009; 182(6): 2607-2612. Doi: 10.1016/j.juro.2009.08.084
Web of Science PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Suardi, N; Capitanio, U; Jeldres, C; Ficarra, V; Cindolo, L; de La Taille, A; Tostain, J; Mulders, PF; Bensalah, K; Artibani, W; Salomon, L; Zigeuner, R; Valeri, A; Descotes, JL; Rambeaud, JJ; Mejean, A; Montorsi, F; Bertini, R; Patard, JJ A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma.
Eur Urol. 2009; 55(2): 287-295. Doi: 10.1016/j.eururo.2008.07.037
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Margulis, V; Shariat, SF; Matin, SF; Kamat, AM; Zigeuner, R; Kikuchi, E; Lotan, Y; Weizer, A; Raman, JD; Wood, CG; Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Cancer. 2009; 115(6): 1224-1233. Doi: 10.1002/cncr.24135 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Remzi, M; Haitel, A; Margulis, V; Karakiewizc, P; Montorsi, F; Kikuchi, E; Zigeuner, R; Weizer, A; Bolenz, C; Bensalah, K; Suardi, N; Raman, JD; Lotan, Y; Waldert, M; Ng, CK; Fernández, M; Koppie, TM; Ströbel, P; Kabbani, W; Murai, M; Langner, C; Roscigno, M; Wheat, J; Guo, CC; Wood, CG; Shariat, SF Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
BJU Int. 2009; 103(3): 307-311. Doi: 10.1111/j.1464-410X.2008.08003.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Roscigno, M; Shariat, SF; Freschi, M; Margulis, V; Karakiewizc, P; Suardi, N; Remzi, M; Zigeuner, R; Bolenz, C; Kikuchi, E; Weizer, A; Bensalah, K; Sagalowsky, A; Koppie, TM; Raman, J; Fernandez, M; Strobel, P; Kabbani, W; Langner, C; Wheat, J; Guo, CC; Kassouf, W; Haitel, A; Wood, CG; Montorsi, F Assessment of the Minimum Number of Lymph Nodes Needed to Detect Lymph Node Invasion at Radical Nephroureterectomy in Patients With Upper Tract Urothelial Cancer
UROLOGY. 2009; 74(5): 1070-1074. Doi: 10.1016/j.urology.2009.04.084
Web of Science FullText FullText_MUG Google Scholar

 

** Roscigno, M; Shariat, SF; Margulis, V; Karakiewicz, P; Remzi, M; Kikuchi, E; Langner, C; Lotan, Y; Weizer, A; Bensalah, K; Raman, JD; Bolenz, C; Guo, CC; Wood, CG; Zigeuner, R; Wheat, J; Kabbani, W; Koppie, TM; Ng, CK; Suardi, N; Bertini, R; Fernandez, MI; Mikami, S; Isida, M; Michel, MS; Montorsi, F Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
J UROL. 2009; 181(6): 2482-2489. Doi: 10.1016/j.juro.2009.02.021
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Roscigno, M; Shariat, SF; Margulis, V; Karakiewicz, P; Remzi, M; Kikuchi, E; Zigeuner, R; Weizer, A; Sagalowsky, A; Bensalah, K; Raman, JD; Bolenz, C; Kassou, W; Koppie, TM; Wood, CG; Wheat, J; Langner, C; Ng, CK; Capitanio, U; Bertini, R; Fernández, MI; Mikami, S; Isida, M; Ströbel, P; Montorsi, F The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
Eur Urol. 2009; 56(3): 512-518. Doi: 10.1016/j.eururo.2009.06.004
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wagner, B; Patard, JJ; Méjean, A; Bensalah, K; Verhoest, G; Zigeuner, R; Ficarra, V; Tostain, J; Mulders, P; Chautard, D; Descotes, JL; de la Taille, A; Salomon, L; Prayer-Galetti, T; Cindolo, L; Valéri, A; Meyer, N; Jacqmin, D; Lang, H Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Eur Urol. 2009; 55(2): 452-459. Doi: 10.1016/j.eururo.2008.07.053
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Pummer, K Predicting cancer-control outcomes in patients after nephron sparing surgery.
Arch Ital Urol Androl. 2009; 81(2): 91-95.
PubMed

 

** Zigeuner, R; Pummer, K Current surgical aspects of renal cell carcinoma
Wien Med Wochenschr. 2009; 159(21-22): 535-542. Doi: 10.1007/s10354-009-0720-6
PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bertini, R; Roscigno, M; Zigeuner, R; Strada, E; Petralia, G; Matloob, R; Angiollilli, D; Sozzi, F; Suardi, N; Da Pozzo, LF; Montorsi, F; Rigatti, P Factors predicting cancer-specific survival in patients with metastatic renal cell carcinoma at diagnosis
European Urology Supplements2009; 8(4):179-179.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60240-2 [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Stage migration of renal cell carcinoma in a European single centre over 23 years: Impact on survival
European Urology Supplements2009; 8(4):156-156.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60147-0 [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R The Leibovich - mayo clinic scoring algorithm for clear cell renal cell carcinoma supplemented by vascular invasion
European Urology Supplements2009; 8(4):154-154.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60141-X [Poster]
Web of Science FullText FullText_MUG

 

** Hellenthal, N; Shariat, SF; Margulis, V; Karakiewicz, PI; Roscigno, M; Bolenz, C; Remzi, M; Weizer, A; Zigeuner, R; Koppie, TM Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration
J CLIN ONCOL. 2009; 27(15):5075--ASCO Annual Meeting; MAY 29-JUN 3, 2009; Orlando, FL, USA. [Poster]
Web of Science

 

** Jeldres, C; Suardi, N; Capitanio, U; Ficarra, V; Zigeuner, R; Tostain, J; Mejean, A; Cindolo, L; Pantuck, AJ; Zini, L; De La Taille, A; Chautard, D; Descotes, JL; Shariat, SF; Valeri, A; Mulders, PFA; Lang, H; Lechevallier, E; Montorsi, F; Karakiewicz, PI; Patard, JJ Post-treatment nomogram for prediction of conditional survival after nephrectomy.
European Urology Supplements2009; 8(4):178-178.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60236-0 [Poster]
Web of Science FullText FullText_MUG

 

** Roscigno, M; Shariat, SF; Bertini, R; Karakiewicz, PI; Capitanio, U; Margulis, V; Remzi, M; Zigeuner, R; Bolenz, C; Kikuchi, E; Weizer, A; Bensalah, K; Lotan, Y; Koppie, TM; Raman, J; Fernandez, M; Ströbel, P; Kabbani, W; Murai, M; Langner, C; Wheat, J; Guo, CC; Haitel, A; Wood, CG; Montorsi, F Removal of at least 8 nodes improves both staging and outcomes in patients with upper tract urothelial carcinoma
European Urology Supplements2009; 8(4):150-150.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60124-X [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Pummer, K Macroscopic versus microscopic vascular tumour invasion in patients with clear cell renal cell carcinoma: Does it make a difference?
J CLIN ONCOL. 2009; 27(15): 5093 - ASCO Annual Meeting; MAY 29-JUN 3, 2009; Orlando, FL, USA. [Poster]
Web of Science

 

** Zigeuner, RE; Shariat, SF; Margulis, V; Lotan, Y; Weizer, A; Roscigno, M; Raman, J; Karakiewicz, PI; Kikuchi, E; Montorsi, F; Koppie, TM; Bolenz, C; Remzi, M; Kassouf, W; Bensalah, K; Fernandez, M; Wood, C; Stroebel, P; Wheat, J; Waldert, M; Oya, M; Guo, C; Ng, C; Kabbani, W; Langner, C Proposal for subclassification of pT3 urothelial cancer of the renal pelvis.
Eurpean Urology Supplements2009; 8(4):150-150.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60123-8 [Poster]
Web of Science FullText FullText_MUG

 

2008

Originalarbeit (Zeitschrift)

** Bensalah, K; Pantuck, AJ; Crepel, M; Verhoest, G; Méjean, A; Valéri, A; Ficarra, V; Pfister, C; Ferrière, JM; Soulié, M; Cindolo, L; De La Taille, A; Tostain, J; Chautard, D; Schips, L; Zigeuner, R; Abbou, CC; Lobel, B; Salomon, L; Lechevallier, E; Descotes, JL; Guillé, F; Colombel, M; Belldegrun, AS; Patard, JJ Prognostic variables to predict cancer-related death in incidental renal tumours.
BJU Int. 2008; 102(10): 1376-1380. Doi: 10.1111/j.1464-410X.2008.07847.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gidaro, S; Schips, L; Cindolo, L; Ziguener, R Laparoscopic nephrectomy for complete renal infarction due to post traumatic renal artery thrombosis.
Arch Ital Urol Androl. 2008; 80(2): 79-81. (- Case Report)
PubMed

 

** Hutterer, GC; Patard, JJ; Jeldres, C; Perrotte, P; de La Taille, A; Salomon, L; Verhoest, G; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulders, PF; Karakiewicz, PI Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram.
BJU Int. 2008; 101(1): 39-43. Doi: 10.1111/j.1464-410X.2007.07170.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Karakiewicz, PI; Jeldres, C; Suardi, N; Hutterer, GC; Perrotte, P; Capitanio, U; Ficarra, V; Cindolo, L; de La Taille, A; Tostain, J; Mulders, PF; Salomon, L; Zigeuner, R; Schips, L; Chautard, D; Valeri, A; Lechevallier, E; Descots, JL; Lang, H; Mejean, A; Verhoest, G; Patard, JJ Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.
Can Urol Assoc J. 2008; 2(6):610-617 Doi: 10.5489/cuaj.978 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Leibl, S; Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology.
APMIS. 2008; 116(1): 27-32. Doi: 10.1111/j.1600-0463.2008.00859.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Karam, JA; Margulis, V; Montorsi, F; Karakiewicz, PI; Lotan, Y; Kikuchi, E; Weizer, A; Zigeuner, R; Bolenz, C; Shariat, SF Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study.
Eur Urol. 2008; 54(4): 961-963. Doi: 10.1016/j.eururo.2008.04.083
PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Zigeuner, R; Pummer, K Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors.
EUR UROL. 2008; 53(4): 720-731. Doi: 10.1016/j.eururo.2008.01.006
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Augustin, H; Fritz, G; Ehammer, T; Zigeuner, R; Pummer, K Comparison of accuracy between 3-Tesla MRI and the Partin Tables for the staging of prostate cancer
EUR UROL SUPPL. 2008; 7(3):283-283.-23rd EAU Annual Congress; Mar 26-29, 2008; Milano, Italy. Doi: 10.1016/S1569-9056(08)60846-5 [Poster]
Web of Science FullText FullText_MUG

 

** Bensalah, KC; Salomon, L; Lang, H; Jacqmin, D; Avakian, R; Vincendeau, S; Guille, F; Manunta, A; Crepel, M; Verhoest, G; Montorsi, F; Bertini, R; Karalkiewicz, P; Ficarra, V; Cindolo, L; Zigeuner, R; Patard, JJ Does laparoscopic radical nephrectomy compare favourably with open radical nephrectomy for incidental PT3 renal tumours? A matched analysis in 130 cases
EUR UROL SUPPL. 2008; 7(3):256-256.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy.. Doi: 10.1016/S1569-9056(08)60737-X [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Is the late occurrence of metastases associated with prolonged survival in renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):260-260.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60754-X [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Sarcomatoid transformation and collecting system invasion: Independent prognostic indicators in patients with renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):133-133.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60248-1 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Macrovascular vs. Microvascular tumour invasion in patients with renal cell carcinoma: Does it make a difference ?
EUR UROL SUPPL. EUROPEAN UROLOGY SUPPLEMENTS 2008; 7(3):134-134.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60253-5 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Tumour necrosis: An independent prognostic indicator for clear cell, as well as papillary renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):135-135.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60258-4 [Poster]
Web of Science FullText FullText_MUG

 

** Jeldres, C; Suardi, N; Ficarra, V; Cindolo, L; De La Taille, A; Salomon, L; Tostain, J; Molders, PF; Zigeuner, R; Prayer-Galetti, T; Chautard, D; Bertini, R; Valeri, A; Lechevallier, EI; Descotes, JL; Lang, H; Mejean, A; Montorsi, F; Petard, JJ; Karakiewicz, P Increasing tumour size is associated with higher rates of high Fuhrman nuclear grade in patients with renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):279-279.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60830-1
Web of Science FullText FullText_MUG

 

** Jeldres, C; Suardi, N; Petard, JJ; Ficarra, V; Cindolo, L; De La Taille, A; Salomon, L; Tostain, J; Mulders, PF; Zigeuner, R; Prayer-Galetti, T; Chautard, D; Valeri, A; Lechevallier, E; Descotes, J; Lang, H; Avakian, R; Bensaleh, K; Mejean, A; Bertini, R; Montorsi, F; Karakiewicz, PI External validation a pre-treatment nomogram for prediction of renal cancer-specific mortality
EUR UROL SUPPL. 23rd Annual EAU (European Association of Urology) Congress2008; 7(3):282-282.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60841-6 [Poster]
Web of Science FullText FullText_MUG

 

** Karakiewicz, PI; Hutterer, GC; Suardi, N; Chromecki, T; Jeldres, C; Kampel-Kettner, K; Innamovic, A; Zigeuner, R; Bensaleh, K; Avakian, R; Shariat, SF; Montorsi, F; Perrotte, P; Patard, JJ Nomogram predicting renal cancer-specific survival in surgically treated patients with metastatic renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):282-282.-23rd Annual EAU (European Association of Urology) Congress; 26-29 March 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60840-4 [Poster]
Web of Science FullText FullText_MUG

 

** Karakiewicz, PI; Jeldres, C; Suardi, N; Ficarra, V; Prayer-Galetti, T; Tostain, J; Mulders, PF; Cindolo, L; De La Taille, A; Salomon, L; Zigeuner, R; Chautard, D; Valeri, A; Lechevallier, E; Bensalah, K; Descotes, JL; Avakian, R; Lang, H; Mejean, A; Patard, JJ T4 stage renal cell carcinoma without any evidence of metastatic disease have similar cancer-specific survival rates as those with nodal metastasis after radical nephrectomy
EUR UROL SUPPL. 2008; 7(3):281-281.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60838-6
Web of Science FullText FullText_MUG

 

** Roscigno, M; Shariat, SF; Bertini, R; Freschi, M; Remzi, M; Haitel, A; Margolis, V; Guo, CC; Wood, CG; Kikuchi, E; Murai, M; Zigeuner, R; Langner, C; Weizer, A; Wheat, J; Bolenz, C; Strobel, P; Lotan, Y; Kabbani, W; Koppie, TM; Casey, KN; Raman, JD; Fernandez, M; Karakiewizc, P; Bensalah, K; Mentors, F More extensive lymphadenectomy improves the prognosis of patients with upper tract urothelial carcinoma without nodal metastases.
EUR UROL SUPPL. 2008; 7(3):221-221.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60597-7 [Poster]
Web of Science FullText FullText_MUG

 

** Roscigno, M; Shariat, SF; Bertini, R; Karakiewizc, P; Suardi, N; Wood, CG; Guo, CC; Margulis, V; Wheat, J; Weizer, A; Langner, C; Zigeuner, R; Rigatti, P; Murai, M; Kikuchi, E; Kabbani, W; Lotan, Y; Raman, JD; Ng, CK; Strobel, P; Bolenz, C; Fernandez, M; Koppie, TM; Freschi, M; Montorsi, F Preoperative factors predicting lymph node invasion in patients with upper tract transitional cell carcinoma
EUR UROL SUPPL. 2008; 7(3):321-321.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60996-3 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Kampel-Kettner, K; Imamovic, A; Langner, C; Rehak, P; Pummer, K The mayo clinic stage, size, grade and necrosis (SSIGN) score for clear cell renal cell carcinoma: External validation by a single European centre applying routine pathology
EUR UROL SUPPL. 2008; 7(3):280-280.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60832-5 [Poster]
Web of Science FullText FullText_MUG

 

Kommentar

** Zigeuner, R Editorial comment on: Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Eur Urol. 2008; 54(4): 873-874. Doi: 10.1016/j.eururo.2008.02.045
PubMed FullText FullText_MUG

 

** Zigeuner, R Editorial comment on: transumbilical single-port surgery: evolution and current status.
Eur Urol. 2008; 54(5): 1029-1029. Doi: 10.1016/j.eururo.2008.07.010
PubMed FullText FullText_MUG

 

2007

Originalarbeit (Zeitschrift)

** Hutterer, GC; Patard, JJ; Perrotte, P; Ionescu, C; de La Taille, A; Salomon, L; Verhoest, G; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Chautard, D; Descotes, JL; Rambeaud, JJ; Mejean, A; Karakiewicz, PI Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram.
Int J Cancer. 2007; 121(11): 2556-2561. Doi: 10.1002/ijc.23010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Karakiewicz, PI; Briganti, A; Chun, FK; Trinh, QD; Perrotte, P; Ficarra, V; Cindolo, L; De la Taille, A; Tostain, J; Mulders, PF; Salomon, L; Zigeuner, R; Prayer-Galetti, T; Chautard, D; Valeri, A; Lechevallier, E; Descotes, JL; Lang, H; Mejean, A; Patard, JJ Multi-institutional validation of a new renal cancer-specific survival nomogram.
J Clin Oncol. 2007; 25(11): 1316-1322. Doi: 10.1200/JCO.2006.06.1218 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Hutterer, GC; Trinh, QD; Pantuck, AJ; Klatte, T; Lam, JS; Guille, F; de La Taille, A; Novara, G; Tostain, J; Cindolo, L; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Chautard, D; Lechevallier, E; Valeri, A; Descotes, JL; Lang, H; Soulie, M; Ferriere, JM; Pfister, C; Mejean, A; Belldegrun, AS; Patard, JJ Unclassified renal cell carcinoma: an analysis of 85 cases.
BJU Int. 2007; 100(4): 802-808. Doi: 10.1111/j.1464-410X.2007.07148.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Trinh, QD; Bhojani, N; Bensalah, K; Salomon, L; de la Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A; Patard, JJ Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
EUR UROL. 2007; 51(6): 1616-1624. Doi: 10.1016/j.eururo.2006.12.015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Karakiewicz, PI; Trinh, QD; Rioux-Leclercq, N; de la Taille, A; Novara, G; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulders, PF; Lechevallier, E; Coulange, C; Valeri, A; Descotes, JL; Rambeaud, JJ; Abbou, CC; Lang, H; Jacqmin, D; Mejean, A; Patard, JJ Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
Eur Urol. 2007; 52(4): 1140-1145. Doi: 10.1016/j.eururo.2007.01.070
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Klatte, T; Patard, JJ; Goel, RH; Kleid, MD; Guille, F; Lobel, B; Abbou, CC; De La Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Artibani, W; Prayer-Galetti, T; Allhoff, EP; Schips, L; Zigeuner, R; Figlin, RA; Kabbinavar, FF; Pantuck, AJ; Belldegrun, AS; Lam, JS Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
J Urol. 2007; 178(1): 35-40. Doi: 10.1016/j.juro.2007.03.046
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Lam, JS; Klatte, T; Patard, JJ; Goel, RH; Guillè, F; Lobel, B; Abbou, CC; De La Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Artibani, W; Prayer-Galetti, T; Schips, L; Zigeuner, R; Pantuck, AJ; Figlin, RA; Belldegrun, AS Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
EUR UROL. 2007; 52(1): 155-162. Doi: 10.1016/j.eururo.2007.01.106
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pollheimer, VS; Bodo, K; Pollheimer, MJ; Zigeuner, R; Langner, C Merkel cell carcinoma metastasizing to the kidney mimicking primary neuroendocrine renal cancer.
APMIS. 2007; 115(6): 774-777. Doi: 10.1111/j.1600-0463.2007.apm_617.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pummer, K; Stettner, H; Augustin, H; Zigeuner, R; Habermann, H; Schips, L; Riedler, I; Trummer, H; Lipsky, K; Williams, SB The use of body mass index to predict pathological stage in patients with clinically localized prostate cancer.
Onkologie. 2007; 30(10): 489-494. Doi: 10.1159/0000106096
Web of Science PubMed FullText FullText_MUG

 

** Rioux-Leclercq, N; Karakiewicz, PI; Trinh, QD; Ficarra, V; Cindolo, L; de la Taille, A; Tostain, J; Zigeuner, R; Mejean, A; Patard, JJ Prognostic ability of simplified nuclear grading of renal cell carcinoma.
Cancer. 2007; 109(5): 868-874. Doi: 10.1002/cncr.22463 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Dalpiaz, O; Lipsky, K; Langner, C; Rehak, P; Puerstner, P; Pummer, K; Zigeuner, R Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Eur Urol. 2007; 51(1): 168-173. Doi: 10.1016/j.eururo.2006.06.026
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Verhoest, G; Veillard, D; Guillé, F; De La Taille, A; Salomon, L; Abbou, CC; Valéri, A; Lechevallier, E; Descotes, JL; Lang, H; Jacqmin, D; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulders, PF; Mejean, A; Patard, JJ Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.
EUR UROL. 2007; 51(5): 1298-1304. Doi: 10.1016/j.eururo.2006.11.056
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Winkler, A; Zigeuner, R; Rehak, P; Hutterer, G; Chromecki, T; Langner, C CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
Virchows Arch. 2007; 450(1):59-64 Doi: 10.1007/s00428-006-0316-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Galfano, A; Zigeuner, R; Tostain, J; Chautard, D; Guile, F; Lang, H; Descotes, JL; Taille, AL; Mulders, PFA; Cindolo, L; Novara, G; Schips, L; Salomon, L; Ficarra, V; Zattoni, F; Artibani, W; Petard, JJ Venous involvement in renal cell carcinoma: Is its impact on prognosis?
EUR UROL SUPPL. 2007; 6(2):235-235.-22. Kongreß der “European Association of Urology” (EAU); 21.3.-24.3.2007; Berlin, Germany. [Poster]
Web of Science

 

** Karakiewicz, PI; Trinh, QD; Bhojani, N; Bensalah, K; Salomon, L; De La Talle, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A; Patard, JJ Presence of systemic symptoms is the foremost predictor of mortality in patients with exclusive nodal metastases
EUR UROL SUPPL. 2007; 6(2):64-64.-22. Kongreß der “European Association of Urology” (EAU); 21.3.-24.3.2007; Berlin, Germany. [Poster]
Web of Science

 

** Karakiewicz, PI; Trinh, QD; Hutterer, GC; Bhojani, N; Bensalah, K; Patard, JJ; Salomon, L; De La Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A A nomogram predicting renal cell carcinoma-specific survival in patients with nodal metastases is more accurate than any individual variable
EUR UROL SUPPL. 2007; 6(2):64-64.-22. Kongreß der “European Association of Urology” (EAU); 21.-24.3.2007; Berlin, Germany. [Poster]
Web of Science

 

** Novara, G; Schips, L; Galfano, A; Guille, F; Tostain, J; Lang, H; Mulders, PFA; Cindolo, L; Chautard, D; Descotes, JL; De La Taille, A; Salomon, L; Zigeuner, R; Mejean, A; Zattoni, F; Artibani, W; Patard, JJ; Ficarra, V Ipsilateral adrenal gland invasion is an unfavourable feature for locally advanced renal cell carcinoma
EUR UROL SUPPL. 2007; 6(2):159-159.-22. Kongreß der “European Association of Urology” (EAU); 21.3.-24.3.2007; Berlin, Germany. Doi: 10.1016/S1569-9056(07)60545-4 [Poster]
Web of Science FullText FullText_MUG

 

** Patard, JJ; Pantuck, AJ; Mejean, A; Valeri, A; Ficarra, V; Artibani, W; Pfister, C; Ferriere, JM; Soulie, M; Cindolo, L; De La Taille, A; Salomon, L; Abbou, C; Tostain, J; Chautard, D; Schips, L; Zigeuner, R; Lechevallier, E; Coulange, C; Descotes, JL; Rambeaud, JJ; Guille, F; Vincendeau, S; Manunta, A; Belldegrun, A; Lam, J; Colombel, M Prediction of cancer-related death in incidentally diagnosed renal cell carcinoma
EUR UROL SUPPL. 2007; 6(2):62-62.-22. Kongreß der “European Association of Urology” (EAU); 21.-24.3.07; Berlin, Germany. Doi: 10.1016/S1569-9056(07)60158-4 [Poster]
Web of Science FullText FullText_MUG

 

** Trinh, QD; Karakiewicz, P; Jeldres, C; Salomon, L; De L Taille, A; Tostain, J; Cindolo, L; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A; Patard, JJ Age is a major determinant of renal cell carcinoma-specific mortality after nephrectomy
EUR UROL SUPPL. 2007; 6(2):63-63.-22. Kongreß der “European Association of Urology” (EAU), ; 21.-24.3.07; Berlin, Germany. Doi: 10.1016/S1569-9056(07)60162-6 [Poster]
Web of Science FullText FullText_MUG

 

** Trinh, QD; Karakiewicz, P; Jeldres, C; Salomon, L; De La Taille, A; Tostain, J; Cindolo, L; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PFA; Valeri, A; Descotes, JL; Mejean, A; Patard, JJ Age is the foremost predictor of cancer-specific mortality in patients with incidentally diagnosed renal cell carcinoma
EUR UROL SUPPL. 2007; 6(2):161-161.-22. Kongreß der “European Association of Urology” (EAU); 21.3.-24.3.2007; Berlin, Germany. Doi: 10.1016/S1569-9056(07)60554-5 [Poster]
Web of Science FullText FullText_MUG

 

** Verhoest, G; Veillard, D; Guille, F; De La Taille, A; Solomon, L; Abbou, C; Valeri, A; Lechevallier, E; Coulange, C; Descotes, JL; Rambeaud, JJ; Lang, H; Jacqmin, D; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulder, P; Mejean, A; Patard, JJ Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma
EUR UROL SUPPL. 2007; 6(2):63-63.-22. Kongreß der “European Association of Urology” (EAU); 21.-24.3.2007; Berlin, Germany. Doi: 10.1016/S1569-9056(07)60163-8 [Poster]
Web of Science FullText FullText_MUG

 

** Wagner, B; Patard, JJ; Mejean, A; Zigeuner, R; Bensalah, K; Schips, L; Ficarra, V; Tostain, J; Mulders, PFA; Chautard, D; Descotes, JL; De La Taille, A; Salomon, L; Cindolo, L; Prayer-Galetti, T; Valeri, A; Meyer, N; Jacqmin, D; Lang, H Prognosis value of renal vein (RV) and inferior vena cava (IVC) involvement in renal cell carcinoma (RCC)
EUR UROL SUPPL. 2007; 6(2):159-159.-22. Kongreß der “European Association of Urology” (EAU); 21.3.-24.3.2007; Berlin, Germany. Doi: 10.1016/S1569-9056(07)60544-2 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Winkler, A; Rehak, P; Langner, C CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression
EUR UROL SUPPL. 2007; 6(2):27-27.-22. Kongreß der “European Association of Urology” (EAU); 21.3.-24.3.2007; Berlin, Germany. Doi: 10.1016/S1569-9056(07)60017-7 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Chromecki, T; Leibl, S; Rehak, P; Langner, C Desmoplasia is an independent prognostic indicator in urothelial carcinoma of the upper urinary tract
J UROL. 2007; 177(4):134-134.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

** Zigeuner, RE; Chromecki, T; Rehak, P; Langner, C Bladder tumor development after urothelial carcinoma of the upper urinary tract is related to primary tumor location
J UROL. 2007; 177(4):134-135.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

** Zigeuner, RE; Chromecki, T; Rehak, P; Langner, C Cox-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumor progression
J UROL. 2007; 177(4):132-133.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

** Zigeuner, RE; Chromecki, T; Winkler, A; Rehak, P; Langner, C CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumor progression
J UROL. 2007; 177(4):132-132.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

2006

Originalarbeit (Zeitschrift)

** Langner, C; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Zigeuner, R Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract.
J UROL. 2006; 176(3): 910-913. Doi: 10.1016/j.juro.2006.04.019
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Hutterer, G; Chromecki, T; Rehak, P; Zigeuner, R Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.
VIRCHOWS ARCHIV. 2006; 448(5): 604-611. Doi: 10.1007/s00428-006-0150-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Hutterer, G; Chromecki, T; Winkelmayer, I; Rehak, P; Zigeuner, R pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract.
MODERN PATHOL. 2006; 19(2): 272-279. Doi: 10.1038/modpathol.3800529 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Rupar, G; Leibl, S; Hutterer, G; Chromecki, T; Hoefler, G; Rehak, P; Zigeuner, R Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
Virchows Arch. 2006; 448(3):325-330 Doi: 10.1007/s00428-005-0129-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Dalpiaz, O; Cestari, A; Lipsky, K; Gidaro, S; Zigeuner, R; Petritsch, P Autologous fibrin glue using the Vivostat system for hemostasis in laparoscopic partial nephrectomy.
Eur Urol. 2006; 50(4): 801-805. Doi: 10.1016/j.eururo.2006.03.010
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Droschl, N; Tauber, V; Rehak, P; Langner, C Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
Urology. 2006; 68(3):518-522 Doi: 10.1016/j.urology.2006.03.032
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, RE; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
BJU Int. 2006; 98(6): 1181-1186. Doi: 10.1111/j.1464-410X.2006.06519.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Lam, JS; Patard, JJ; Goel, RH; Guille, F; Lobel, B; Abbou, CC; Chopin, DK; De La Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Artibani, W; Prayer-Galetti, T; Schips, L; Zigeuner, RE; Pantuck, AJ; Figlin, RA; Belldegrun, AS Significance of tumor size in locally advanced renal cell carcinoma (pT3a): An international multicenter experience
J UROL. ; 175: 234-234.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32959-8 [Poster]
Web of Science FullText FullText_MUG

 

** Lam, JS; Patard, JJ; Goel, RH; Guille, F; Lobel, B; Abbou, CC; Chopin, DK; De La Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Artibani, W; Prayer-Galetti, T; Schips, L; Zigeuner, RE; Pantuck, AJ; Figlin, RA; Belldegrun, AS Can pT2 classification for renal cell carcinoma be improved? An international multicenter experience?
J UROL. ; 175: 240-241.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32976-8 [Poster]
Web of Science FullText FullText_MUG

 

** Lipsky, K; Zigeuner, RE; Rehak, P; Schips, L; Langner, C Late onset of metastasis after surgery for renal cell cancer prefers unusual locations
J UROL. ; 175: 362-362.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Gorigia. Doi: 10.1016/S0022-5347(18)33351-2 [Poster]
Web of Science FullText FullText_MUG

 

** Rioux-Leclercq, N; Leray, E; Fergelot, P; Mejean, A; Valeri, A; Ficarra, V; Cindolo, L; De La Taille, A; Tostain, J; Chautard, D; Schips, L; Zigeuner, RE; Abbou, CC; Lobel, B; Guille, F; Salomon, L; Lechevallier, E; Descottes, JL; Patard, JJ The nuclear Furhman grade: A European multicenter study for the determination of the optimal grading system in term of prognosis
J UROL. ; 175: 242-242.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Gorgia. Doi: 10.1016/S0022-5347(18)32981-1 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Droschl, N; Tauber, V; Rehak, P; Langner, C HSP27 expression in primary and metastatic renal cell carcinoma
J UROL. ; 175: 129-129.-AUAU Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32652-1 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract.
J UROL. 175: 351-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)33318-4 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Impact of tumor stage, tumor grade, and vascular invasion on metastasis-free survival of patients with urothelial carcinoma of the upper urinary tract.
J UROL. ; 175: 352-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)33319-6 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract correlates with disease progression and metaplastic morphology
J UROL. ; 175: 239-239.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32971-9 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression
J UROL. 2006; 175: 132-132.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32661-2 [Poster]
Web of Science FullText FullText_MUG

 

2005

Originalarbeit (Zeitschrift)

** Cindolo, L; de la Taille, A; Schips, L; Zigeuner, RE; Ficarra, V; Tostain, J; Artibani, W; Gallo, A; Salzano, L; Patard, JJ Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database.
UROLOGY. 2005; 65(4): 681-686. Doi: 10.1016/j.urology.2004.11.005
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Cindolo, L; Patard, JJ; Chiodini, P; Schips, L; Ficarra, V; Tostain, J; de La Taille, A; Altieri, V; Lobel, B; Zigeuner, RE; Artibani, W; Guillé, F; Abbou, CC; Salzano, L; Gallo, C Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
CANCER. 2005; 104: 1362-1371. Doi: 10.1002/cncr.21331 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ficarra, V; Guillè, F; Schips, L; de la Taille, A; Prayer Galetti, T; Tostain, J; Cindolo, L; Novara, G; Zigeuner, R; Bratti, E; Li, G; Altieri, V; Abbou, CC; Zanolla, L; Artibani, W; Patard, JJ Proposal for revision of the TNM classification system for renal cell carcinoma.
Cancer. 2005; 104(10):2116-2123 Doi: 10.1002/cncr.21465 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ficarra, V; Schips, L; Guillè, F; Li, G; De La Taille, A; Prayer Galetti, T; Cindolo, L; Novara, G; Zigeuner, RE; Bratti, E; Tostain, J; Altieri, V; Abbou, CC; Artibani, W; Patard, JJ Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.
CANCER. 2005; 104: 968-974. Doi: 10.1002/cncr.21254 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Gross, C; Rehak, P; Ratschek, M; Rüschoff, J; Zigeuner, R HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique.
Urology. 2005; 65(1):176-180 Doi: 10.1016/j.urology.2004.08.025
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Ratschek, M; Rehak, P; Tsybrovskyy, O; Zigeuner, R The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology?
BJU INT. 2005; 95(3): 310-314. Doi: 10.1111/j.1464-410X.2005.05289.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Rupar, G; Beham-Schmid, C; Gallé, G; Zigeuner, R; Langner, C Interdigitating dendritic cell sarcoma of urinary bladder mimicking large intravesical calculus.
UROLOGY. 2005; 66(5): 1109-1109. Doi: 10.1016/j.urology.2005.05.002 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Lipsky, K; Hebel, P; Hutterer, G; Gidaro, S; Petritsch, PH; Zigeuner, RE Laparoscopic fenestration of lymphoceles after kidney transplantation with diaphanoscopic guidance.
UROLOGY. 2005; 66(1): 185-187. Doi: 10.1016/j.urology.2005.02.020
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Ratschek, M; Langner, C Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
BJU INT. 2005; 95(3): 315-318. Doi: 10.1111/j.1464-410X.2005.05290.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Zigeuner, RE; Langner, C; Rehak, P; Auprich, M; Lipsky, K; Pummer, K; Schips, L Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
J UROL 2005 173: 98-98. Doi: 10.1016/S0022-5347(18)34612-3
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; von Wasielewski, R; Ratschek, M; Ehak, P; Langner, C Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique
J UROL 2005 173: 170-170. Doi: 10.1016/S0022-5347(18)34864-X
Web of Science FullText FullText_MUG

 

2004

Originalarbeit (Zeitschrift)

** Langner, C; Ratschek, M; Rehak, P; Schips, L; Zigeuner, R Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors.
J UROL. 2004; 171(2 Pt 1): 611-614. Doi: 10.1097/01.ju.0000108040.14303.c2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Ratschek, M; Rehak, P; Schips, L; Zigeuner, R Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?
J CLIN PATHOL. 2004; 57(7): 773-775. Doi: 10.1136/jcp.2003.015743 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Ratschek, M; Rehak, P; Schips, L; Zigeuner, R CD10 is a diagnostic and prognostic marker in renal malignancies.
Histopathology. 2004; 45(5):460-467 Doi: 10.1111/j.1365-2559.2004.01982.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Ratschek, M; Rehak, P; Schips, L; Zigeuner, R Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases.
MODERN PATHOL. 2004; 17(2): 180-188. Doi: 10.1038/modpathol.3800032 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Langner, C; von Wasielewski, R; Ratschek, M; Rehak, P; Zigeuner, R Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Urology. 2004; 64(3):611-616 Doi: 10.1016/j.urology.2004.04.072
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; von Wasielewski, R; Ratschek, M; Rehak, P; Zigeuner, R Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique.
Virchows Arch. 2004; 445(6):631-636 Doi: 10.1007/s00428-004-1121-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Wegscheider, BJ; Ratschek, M; Schips, L; Zigeuner, R Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors.
VIRCHOWS ARCHIV. 2004; 444(2): 127-134. Doi: 10.1007/s00428-003-0948-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Wegscheider, BJ; Rehak, P; Ratschek, M; Zigeuner, R Prognostic value of keratin subtyping in transitional cell carcinoma of the upper urinary tract.
VIRCHOWS ARCHIV. 2004; 445(5): 442-448. Doi: 10.1007/s00428-004-1088-z
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Lipsky, K; Zigeuner, R; Zischka, M; Schips, L; Pummer, K; Rehak, P; Hubmer, G Selenium levels of patients with newly diagnosed prostate cancer compared with control group.
UROLOGY. 2004; 63(5): 912-916. Doi: 10.1016/j.urology.2003.12.028
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Lipsky, K; Zigeuner, R; Gidaro, S; Salfellner, M; Rehak, P; Pummer, K; Hubmer, G Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients.
J SURG ONCOL. 2004; 88(2): 57-61. Doi: 10.1002/jso.20139
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Zigeuner, R; Ratschek, M; Rehak, P; Rüschoff, J; Langner, C Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma.
AMER J CLIN PATHOL. 2004; 122(6): 931-937. Doi: 10.1309/G7PY-0RE7-T86H-HQYV [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Ratschek, M; Rehak, P; Schips, L; Langner, C Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
UROLOGY. 2004; 63(4): 651-655. Doi: 10.1016/j.urology.2003.11.011
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Tsybrovskyy, O; Ratschek, M; Rehak, P; Lipsky, K; Langner, C Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
UROLOGY. 2004; 63(6): 1079-1083. Doi: 10.1016/j.urology.2004.01.009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Langner, C; Ratschek, M; Rehak, P; Schips, L; Zigeuner, R Expression of p27(kip1)and its ubiquitin ligase subunit Skp2 in renal cell and upper urinary tract transitional cell carcinoma
J UROL 2004 171: 265-265. Doi: 10.1016/S0022-5347(18)38240-5
Web of Science FullText FullText_MUG

 

** Langner, C; Ratschek, M; Rehak, P; Schips, L; Zigeuner, R CD10 is a biomarker in renal tumor pathology with both diagnostic and prognostic impact
J UROL 2004 171: 201-202. Doi: 10.1016/S0022-5347(18)38008-X
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Ratschek, M; Rehak, P; Schips, L; Langner, C Differential diagnosis between conventional and chromophobe renal cell carcinomas is facilitated by combined application of immunohistochemical markers
J UROL 2004 171: 265-265. Doi: 10.1016/S0022-5347(18)38238-7
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Ratschek, M; Rehak, P; Schips, L; Langner, C Expression of MUC1 (EMA) in renal cell carcinomas: A systematic immunohistochemical analysis of 175 cases
J UROL 2004 171: 200-200. Doi: 10.1016/S0022-5347(18)38002-9
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Ratschek, M; Rehak, P; Tsybrovskyy, O; Langner, C Renal cell carcinomas of TNM stages pT1a and pT1b: Are differences in outcome reflected by differences in pathology?
J UROL 2004 171: 264-264. Doi: 10.1016/S0022-5347(18)38235-1
Web of Science FullText FullText_MUG

 

2003

Originalarbeit (Zeitschrift)

** Langner, C; Ratschek, M; Tsybrovskyy, O; Schips, L; Zigeuner, R P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.
J Histochem Cytochem. 2003; 51(8):1097-1099 Doi: 10.1177/002215540305100813 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Lipsky, K; Zigeuner, R; Salfellner, M; Winkler, S; Langner, C; Rehak, P; Pummer, K; Hubmer, G Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients.
Urology. 2003; 62(6):1024-1028 Doi: 10.1016%2FS0090-4295%2803%2900763-5
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Ratschek, M; Gallé, G; Zigeuner, R; Trummer, H; Petritsch, PH; Hubmer, G Angiomyolipoma with a caval thrombus.
Urol Int. 2003; 70(4):332-334 Doi: 10.1159/000070147 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Schips, L; Zigeuner, R; Lipsky, K; Quehenberger, F; Salfellner, M; Winkler, S; Pummer, K; Hubmer, G Do patients with a higher body mass index have a greater risk of advanced-stage renal cell carcinoma?
Urology. 2003; 62(3):437-441 Doi: 10.1016%2FS0090-4295%2803%2900380-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, R; Quehenberger, F; Pummer, K; Petritsch, P; Hubmer, G Long-term results of nephron-sparing surgery for renal cell carcinoma in 114 patients: risk factors for progressive disease.
BJU Int. 2003; 92(6):567-571 Doi: 10.1046%2Fj.1464-410X.2003.04414.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zigeuner, R; Schips, L; Lipsky, K; Auprich, M; Salfellner, M; Rehak, P; Pummer, K; Hubmer, G Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies.
Urology. 2003; 62(5):883-887 Doi: 10.1016/S0090-4295(03)00663-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, RE; Lipsky, K; Riedler, I; Auprich, M; Schips, L; Salfellner, M; Pummer, K; Hubmer, G Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients.
Urology. 2003; 62(3):451-455 Doi: 10.1016%2FS0090-4295%2803%2900459-X
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, RE; Riesenberg, R; Pohla, H; Hofstetter, A; Oberneder, R Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro.
J UROL. 2003; 169(2): 701-705. Doi: 10.1097/01.ju.0000038953.11811.82
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Schips, L; Lipsky, K; Zigeuner, RE; Hubmer, G; Ratschek, M; Rehak, P; Langner, C Immunohistochemical analysis of insulin-like growth factor-I and II and insulin-like growth factor I receptor expression in renal cell carcinoma
J UROL 2003 169: 209-209.
Web of Science

 

** Zigeuner, RE; Schips, L; Lipsky, K; Rehak, P; Hubmer, G; Ratschek, M; Langner, C P53-overexpression in renal cell carcinoma is associated with histological subtypes
J UROL 2003 169: 199-199.
Web of Science

 

2002

Originalarbeit (Zeitschrift)

** Schips, L; Augustin, H; Zigeuner, RE; Gallé, G; Habermann, H; Trummer, H; Pummer, K; Hubmer, G Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?
Urology. 2002; 59(2):220-223 Doi: 10.1016%2FS0090-4295%2801%2901522-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schips, L; Zigeuner, RE; Langner, C; Mayer, R; Pummer, K; Hubmer, G Metastasis of an ascending colon carcinoma in the prostate 10 years after hemicolectomy.
J Urol. 2002; 168(2):641-642 Doi: 10.1097%2F00005392-200208000-00055 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Langner, C; Schips, L; Zigeuner, RE; Humer-Fuchs, U; Hubmer, G Metastatic colon carcinoma in the prostate 10 years after hemicolectomy - Significance of cytokeratin typing
J PATHOL 2002 198: 21A-21A.
Web of Science

 

2001

Editorial

** Augustin, H; Schips, L; Vilits, P; Zigeuner, R; Petritsch, HP; Uggowitzer, M; Hubmer, G Handicap of walking by a huge paratesticular liposarcoma.
Urol Int. 2001; 66(4):229-230 Doi: 10.1159/000056622 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2000

Originalarbeit (Zeitschrift)

** Zigeuner, RE; Riesenberg, R; Pohla, H; Hofstetter, A; Oberneder, R Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro.
J Urol. 2000; 164(5):1834-1837 Doi: 10.1097%2F00005392-200011000-00111
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Originalarbeit (Zeitschrift)

** Ruppert-Kohlmayr, AJ; Stacher, R; Preidler, KW; Zigeuner, R; Primus, G; Ricabonna, M; Szolar, DH Native spiral computerized tomography in patients with acute flank pain--sense or nonsense?
Rofo. 1999; 170(2):168-173 Doi: 10.1055/s-2007-1011030
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Originalarbeit (Zeitschrift)

** Colombo, T; Zigeuner, R; Zitta, S; Petritsch, PH; Hubmer, G Orthotopic neobladder in a woman after kidney transplantation.
J Urol. 1997; 158(6):2236-2237 Doi: 10.1016/S0022-5347(01)68212-0 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1996

Originalarbeit (Zeitschrift)

** Colombo, T; Zigeuner, R; Altziebler, S; Pummer, K; Stettner, H; Hubmer, G Effect of extracorporeal shock wave lithotripsy on prostate specific antigen.
J Urol. 1996; 156(5):1682-1684 Doi: 10.1097%2F00005392-199611000-00038
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum